EurekaMag Full Text Articles Chapter 35,323
References:
Hattab, E.M.; Goldberger, B.A.; Johannsen, L.M.; Kindland, P.W.; Ticino, F.; Chronister, C.W.; Bertholf, R.L. 2000: Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine Use for detecting maternal and neonatal drug exposures. Annals Of Clinical and Laboratory Science. 30(1): 85-91,.
Pastor, J.J.; Fernandez, I.; Rabanal, F.; Giralt, E. 2002: Modification of secondary structures by combinatorial chemistry A new solid phase based screening test for protein folding detection. Journal of Peptide Science 8(Suppl): S217
Bustos, M.M.; Chern, M.S.enq 2000: Modification of seed crops with transcription factors. Official Gazette of the United States Patent and Trademark Office Patents 1241(2)
Benna, P.; Montalenti, E.; Imperiale, D.; Rovera, A. 2000: Modification of seizure semeiology during add-on treatment with topiramate in partial epilepsy Two case reports. Epilepsia 41(Suppl 7): 124
Mann, J.R.; Stine, C.C. 2003: Modification of sexual behaviors is important for the prevention of human papillomavirus infection. Journal of Infectious Diseases 188(1): 177
Ribaric, S.; Rozman, J.; Sketelj, J. 2000: Modification of skeletal muscle AChE expression by a novel method of stimulus application to the peripheral nerve. Pflugers Archiv: European Journal of Physiology 439(3 Suppl): R217-R219
Lewis, M.P.; Dodgson, L.; Singh, A.; Hunt, N.P.; Tippett, H.L. 2002: Modification of skeletal muscle regeneration by anti-proteases. Biochemical Society Transactions 30(1): A40
Dore', C.; Noordenbos, J.; Hansbrough, W.; Hansbrough, J. 1999: Modification of skin graft donor site care using a continuous quality improvement process. Journal of Burn Care and Rehabilitation 20(1 Part 2): S154
Nagasaki, A. 2000: Modification of sliding skin graft for rectal mucosal prolapse subsequent to imperforate anus surgery. Journal of the Japan Society of Coloproctology 53(3): 194-195
Rubboli, G.; Michelucci, R.; Riguzzi, P.; Zamagni, M.; Meletti, S.; Gardella, E.; Zaniboni, A.; D.Orsi, G.; Testoni, S.; Bisulli, A.; Tassinari, C.A. 1999: Modification of snoring as unusual ictal manifestation A polygraphic study. Epilepsia 40(Suppl 2): 28
Kikusui, T.; Nakamura, K.; Isaka, Y.; Takeuchi, Y.; Mori, Y. 2003: Modification of social behaviors following precocious weaning in mice. Hormones and Behavior 44(1): 57-58
Shewmaker, C. 2000: Modification of soluble solids in fruit using sucrose phosphate synthase encoding sequence. Official Gazette of the United States Patent and Trademark Office Patents 1238(4)
Kole, R. 2000: Modification of splicing pathways by antisense oligonucleotides. Abstracts of Papers American Chemical Society 219(1-2): CARB 3
Wong, T.P.; Casu, M.; Ribeiro Da Silva, A.; Cuello, A.C.; De Koninck, Y. 1999: Modification of spontaneous synaptic activity in layer V neocortical pyramidal neurons with aging. Society for Neuroscience Abstracts 25(1-2): 1996
Hermann, S.; Pixberg, M.; Theobald, I.; Hunhold, A.; Juergens, H.; Schober, O.; Franzius, C. 2003: Modification of staging in childhood lymphoma with FDG PET as compared to CT. Journal of Nuclear Medicine 44(5 Suppl): 346P
Broglie, K.E.; Lightner, J.E.ward 2002: Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)
Burrell, M.M.; Coates, S.A.; Weir, A.F. 2000: Modification of starch content in plants. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)
Fujisaki, M.; Chiba, T. 2000: Modification of stress response after lesioning of posterior amygdaloid nucleus Evaluated by immediate early genes expression and behavior. Neuroscience Research Suppl (24): S175
Bruet, N.; Windels, F.; Bertrand, A.; Chatellard Causse, C.; Feuerstein, C.; Benabid, A.L.; Savasta, M. 1999: Modification of striatal dopamine release after electrical stimulation of the subthalamic nucleus in normal and partially dopaminergic denervated rats A microdialysis study. Society for Neuroscience Abstracts 25(1-2): 1344
Blundy, K.S.; Burrell, M.M.; Morris, G.S.; Thomas, C.J. Robert 2001: Modification of sucrose accumulation in the tubers of potatoes. Official Gazette of the United States Patent and Trademark Office Patents 1250(4)
Van Assche, C.; Lando, D.; Bruneau, J.M.; Voelker, T.A.; Gervais, M. 1999: Modification of sucrose phosphate synthase in plants. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)
West, N.E.J.; Guzik, T.J.; Black, E.A.; Channon, K.M. 2001: Modification of superoxide-nitric oxide interactions in experimental venous bypass graft pathobiology by NOS gene transfer. European Heart Journal 22(Abstract Suppl): 624
Langer, R.S.; Cannizzaro, S.M.; Mueller, B.G.; Shakesheff, K. 2004: Modification of surfaces using biological recognition events. Official Gazette of the United States Patent and Trademark Office Patents 1287(1)
Barria, A.; Malinow, R. 1999: Modification of synaptic plasticity by a no-stimulation period. Society for Neuroscience Abstracts 25(1-2): 736
Hasegawa, J.; Morotomi, K.; Tachibana, M. 2003: Modification of synaptic transmission by glutamate transporter in mouse retina. Neuroscience Research Suppl (26): S37
Guerrero, R.; Sanchez Pernaute, O.; Acebes, C.; Llorens, M.A.; Mas, S.; Palacios, I.; Egido, J.; Vivanco, F.; Herrero Beaumont, G. 1999: Modification of synovial cartilage markers after repetitive intraarticular administration of hyaluronate in knee OA patients. Arthritis and Rheumatism 42(9 Suppl): S253
Nissim Rafinia, M.; Chiba Falek, O.; Kerem, B. 2000: Modification of the CFTR splicing pattern by cellular and viral splicing factors in CFTR expressing cells. American Journal of Human Genetics 67(4 Suppl 2): 38
Snyder, R.D. 2001: Modification of the Chinese hamster V79 in vitro micronucleus assay for the detection of DNA intercalating agents. Mutation Research 483(Suppl 1): S97-S98, 20 October
Pardini, M.I.M.C.; Grotto, R.M.T.; Bombonato, V.; Souza, L.R.; Goncalves, M.B.C.; Meira, D.A.; Machado, P.E.A. 2002: Modification of the HIV-1 plasma viral load in response to the anturetriviral therapy. Vox Sanguinis 83(Suppl 2): 54
Emir, H.; Jayanthi, V.R.; Nitarahara, K.; Danismend, N.; Koff, S.A. 1999: Modification of the Koyanagi technique for single stage repair of proximal hypospadias Long term results. Pediatrics 104(3 Part 3): 812
Morita, S.; Hando, K.; Ishijima, A.; Yuasa, S.; Sato, K.; Nakamura, M.; Kano, K.; Shibata, Y. 2000: Modification of the MPHA test for platelet cross-matching. Vox Sanguinis 78(Suppl 1): P039
Lo, W.D.; Akhmametyeva, E.; Chang, L.S.eng 2002: Modification of the N terminal portion of the anti-apoptotic p35 gene attenuates anti-caspase activity in neuronal cells. Pediatric Research 51(4 Part 2): 445A
Contreras, R.H.; Vervecken, W.; Callewaert, N.; Geysens, S.; Kaigorodov, V. 2003: Modification of the N-glycosylation pathway of lower eukaryotes to a mammalian type. Abstracts of Papers American Chemical Society 225(1-2): BIOT 30
Fritz, K.I.; Ashraf, O.M.; Ballesteros, J.R.; Mishra, O.P.; Delivoria Papadopoulos, M. 2000: Modification of the NR2A subunit of the N-methyl-D-aspartate receptor during graded hypoxia in the cerebral cortex of newborn piglets. Pediatric Research 47(4 Part 2): 398A
Vasilets, L.A.; Spielmann, A.; Schwarz, W. 2003: Modification of the PKC phosphorylation site Ser-23 of the rat alpha1 subunit. Annals of the new York Academy of Sciences 986: 543-545
Ausheva, Z.I.; Tsoloyeva, Z.A. 2003: Modification of the absorption-elution reaction in examining the contaminated biological objects. Sudebno-Meditsinskaya Ekspertiza 46(2): 44
Shimizu, Y.; Kubo, T.; Furukawa, Y. 1999: Modification of the accumulative inactivation of Shaker-type K+ channels by patch excision. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 124(Suppl ): S96
Hauck, C.; Moersig, W.; Horn, S.; Wallrath, A.; Kunz, H.; Oelert, H. 2001: Modification of the adhesive behaviour of human lung cancer cells on human endothelial cells by synthetic Sialyl-Lewisx. Journal of Cancer Research and Clinical Oncology 127(Suppl 1): S56
Kramp, K.L.; Buck, K.; Slunt, K.M.; Houston, T.A. 2000: Modification of the antileishmanial drug pentamidine to target the cell-surface lipophosphoglycan Toward selective drug delivery. Abstracts of Papers American Chemical Society 220(Part 1): CARB 14
Arsenov, D.V.; Babitskaya, S.V.; Vashkevich, I.I.; Golubeva, M.B.; Kisel', M.A.; Kuz'mitskii, B.B.; Mashkovich, A.E.; Slabkevich, N.M.; Strel'chenok, O.A. 2002: Modification of the antineoplastic effect of doxorubicin by complexes of alpha-fetoprotein with amphiphilic compounds based on polyenoic fatty acids. Khimiko-Farmatsevticheskii Zhurnal 36(9): 17-19
Kipp, B.H.; Kelley, P.M.; Njus, D. 1999: Modification of the ascorbate-binding site of cytochrome b561 by diethylpyrocarbonate. Biophysical Journal 76(1 Part 2): A425
Ernst, S.; Ouyang, F.; Goya, M.; Vogtmann, T.; Schaumann, A.; Baensch, D.; Antz, M.; Kuck, K.H. 2002: Modification of the atrial substrate by left atrial linear lesions in symptomatic patients after pulmonary vein isolation. European Heart Journal 23(Abstract Suppl): 608
Ohgi, K.; Kodaka, A.; Iwama, M.; Tsuji, T.; Irie, M.; Inokuchi, N.; Koyama, T. 2000: Modification of the base specificity of B2 base recognition site of RNase Rh by site-directed mutagenesis of Q32 and S93. Biochemical Society Transactions 28(5): A262
Daudali, B.; Stolnik, S.; Church, A.; Illum, L.; Davis, S.S. 2000: Modification of the biological uptake of colloidal systems by alteration of their surface coverage with PEO block copolymer. Journal of Controlled Release 64(1-3): 311-314
Chow, K.B.S.; Li, H.; Kobayashi, T.; Wise, H. 1999: Modification of the carboxyl-terminal tail of the prostacyclin receptor results in a constitutively-active mutant receptor. FASEB Journal 13(4 Part 1): A462
Cao, M.; Helmann, J.D. 2000: Modification of the cell wall teichoic acids is regulated by an ECF sigma factor in Bacillus subtilis. Abstracts of the General Meeting of the American Society for Microbiology 100: 356-357
Mcgowan, J.E.; Mcknight, A.J.; Zhu, A.; Sadowska, G.B.; Petersson, K.H.; Stonestreet, B.S. 2000: Modification of the cerebral N-methyl-D-aspartate receptor after multiple courses of antenatal steroids in the ovine fetus. Pediatric Research 47(4 Part 2): 416A
Fritz, K.I.; Ashraf, Q.M.; Wu, S.; Mishra, O.P.; Delivoria Papadopoulos, M. 1999: Modification of the cerebral NMDA receptor NR2B subunit during graded hypoxia in newborn piglets. Pediatric Research 45(4 Part 2): 198A
Dusinska, M.; Panakova, D.; Vlcek, D.; Collins, A.R. 2001: Modification of the comet assay with acridine orange staining in Chlamydomonas reinhardtii. Mutation Research 483(Suppl 1): S172-S173, 20 October
Shimizu, M.; Losos, J.; Lampard, G.; Verrinder Gibbins, A.M. 2002: Modification of the complete chicken lysozyme gene by poxvirus mediated recombination. Transgenic Research 11(1): 90-91
Liszewska, F.; Blaszczyk, A.; Sirko, A. 2000: Modification of the cysteine biosynthesis pathway in higher plants Characterization of transgenic tobacco plants producting bacterial SAT and OAS-TL. Biochemical Society Transactions 28(5): A262
Spitzmaul, G.; Dilger, J.; Bouzat, C. 2001: Modification of the desensitization kinetics of the nicotinic receptor by quinacrine. Cellular and Molecular Neurobiology 21(2): 163
Schaneberg, B.T.; Sneden, A.T. 1999: Modification of the diene moiety of maytansine and its homologs. Abstracts of Papers American Chemical Society 218(1-2): ORGN 161
Kantak, K.M. 2000: Modification of the discriminative stimulus effects of cocaine by the nitric oxide synthase inhibitor L-NAME. Glick, Stanley D Author, Maisonneuve, Isabelle M Author Annals of the New York Academy of Sciences; New Medications for drug abuse 265-266
Edenfeld, J.; Schopper, B.; Al Hasani, S.; Diedrich, K. 2000: Modification of the hemizona assay using a 148 mum diode laser for bisecting oocytes into two identical hemizonae and their successful use in the HZA A novel approach. Human Reproduction 15(Abstract Book 1): 106
Karp, B.I.; Ali, S.; Takenaka, T.; Brady, R.O.; Medin, J.A. 1999: Modification of the human alphagalactosidaseA C-terminus enhances uptake by Fabry patient fibroblast. FASEB Journal 13(7): A1403
Barbier, P.; Salice, P.; Mannarino, S.; Fesslova, V.; Braga, M.; Ghiglia, S.; De Sanctis, M.; Ardissino, G.; Fossali, E.; Gioventu, M. 2001: Modification of the left ventricular mass index in hypertensive newborns and infants. European Heart Journal 22(Abstract Suppl): 24
Meier, P.P.; Murtaugh, M.; Vasan, U.; Meier, W.A.; Schanler, R.J. 1999: Modification of the lipid concentration in own mothers milk feedings in the neonatal intensive care unit Clinical application of the creamatocrit technique. Pediatric Research 45(4 Part 2): 287A
Faria, D.; Mazalli, M.; Salvador, D.; Correa, S.; Ito, D. 2001: Modification of the lipid profile of eggs yolks by feeding laying hens different sources of fatty acids. Journal of Dairy Science 84(Suppl 1): 480
Xiang, D. Jin, L. Zhu, Z.Y.; Liu, D.Z. 2000: Modification of the manual Polybrene method and the practical application. Vox Sanguinis 78(Suppl 1): P077
Lawlor, T.E.; Orantes, C.E.; Gulick, A.; Burnett, K.; Mccrea, R.; Mecchi, M.S. 1999: Modification of the microsuspension assay for use as a sensitive bacterial mutation screening tool. Environmental and Molecular Mutagenesis 33(Suppl 33): 39
Hofmann, E.R.; Lamberton, J.S.; Dugan, L.C.; Christian, A.T. 2003: Modification of the molecular composition of siRNA molecules permits gene silencing in bacteria. Environmental and Molecular Mutagenesis 41(3): 178
L.B.zec, S.; Bourbonnais, D.; Bouisset, S. 2000: Modification of the muscular coordination plan in line with fatigue in the focal and postural chain. Archives of Physiology and Biochemistry 108(1-2): 213
Neunlist, M.; Barouk, J.; Just, I.; Leborgne, J.; Galmiche, J.P.ul 2002: Modification of the neuronal phenotype of human submucosal neurons by toxin B of clostridium difficile Role of interleukin-1beta and cyclooxygenase-2. Gastroenterology 122(4 Suppl 1): A 38
Schroeder, A.; Delling, G.; Kaiser, E.A. 2000: Modification of the non-receptor protein tyrosine kinases FAK and PYK2 in response to dexamethasone-, PDGF-, PTH-stimulation and fibronectin engagement in osteoblastic cells. Journal of Bone and Mineral Research 15(Suppl 1): S506
Calle, A.P.; Garcia, J.J.; Diez, M.J.; Fernandez, N.; Grupo, F. Sierra, M. 2000: Modification of the oral absorption of ethinylestradiol in the presence of two dietary fibers. Methods and Findings in Experimental and Clinical Pharmacology 22(6): 468
Barth, T.; Pencheva, N.; Barthova, J.; Velek, J.; Jezek, J.; Kasicka, V.; Machova, A.; Hauzerova, L.; Ubik, K. 2002: Modification of the peptide bond in N-terminal part of deaminovasopressin. Dokladi na B"lgarskata Akademiya na Naukite 55(12): 35-40
Kenealy, W.R.; Klungness, J.; Tshabalala, M.A.; Akhtar, M.; Horn, E.; Gleisner, R.; Buschle Diller, G. 2003: Modification of the physical properties of lignocellulosic materials by laccase. Abstracts of Papers American Chemical Society 225(1-2): CELL 17
Adzerikho, I.E.; Mrochek, A.G.; Dmitriev, V.V.; Minchenja, V.T.; Rachok, S.M. 2000: Modification of the plasmin system in thrombolysis during intravascular co-administration of steptokinase and low frequency ultrasound in vivo. Zeitschrift fuer Kardiologie 89(9): 899
Casal, J.; Yuste, J.; Jado, I.; Fenoll, A.; Gimenez, M.J.; Aguilar, L. 2001: Modification of the pneumococcal bacteremic profile by beta-lactam treatment in a mice sepsis model. International Journal of Antimicrobial Agents 17(Suppl 1): S29
Fisher, T.C.; Armstrong, J.K.; Wenby, R.B.; Meiselman, H.J. 1999: Modification of the red blood cell to alter aggregation - A useful tool for hemorheology studies. Biorheology 36(1-2): 62-63
Gatellier, L.; Nagao, T.; Kanzaki, R. 2003: Modification of the silkmoth pheromone-searching behavior by circadian rhythm and serotonin. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 134A(1): 220
Dion, L.; Malouin, F.; Mcfadyen, B.J.; Richards, C.L. 1999: Modification of the sit-to-walk task after stroke. Society for Neuroscience Abstracts 25(1-2): 907
Kawahara, K.; Tsukano, H.; Watanabe, H.; Lindner, B.; Matsuura, M. 2002: Modification of the structure and activity of Yersinia pestis lipid A by growth temperature. Journal of Endotoxin Research 8(3): 166
Fisher, T.C.; Armstrong, J.K.; Wenby, R.B.; Meiselman, H.J. 1999: Modification of the surface properties of human erythrocytes by covalent attachment of polymers. Biorheology 36(1-2): 53
Braun, W.E. 2000: Modification of the treatment of gout in renal transplant recipients. Transplantation Proceedings 32(1): 199
Tanaka, Y.; Goedegebuure, P.S.; Eberlein, T.J. 2000: Modification of the tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes. Proceedings of the American Association for Cancer Research 41: 699
Lee, S.D.; Dorian, P.; Newman, D.M. 2000: Modification of the ventricular tachyarrhythmia substrate by combined class Ia and class III drug treatment Role of use dependency. Franz, Michael R Monophasic action potentials: Bridging cell and bedside 471-491
Clarke, H.; Marano, C.W.; Peralta Soler, A.; Mullin, J.M. 2000: Modification of tight junction function by protein kinase C isoforms. Advanced Drug Delivery Reviews 41(3): 283-301
Ezpeleta, O.; Alvarez, L.; Arbillaga, L.; Lopez, D.C.rain, A. 2003: Modification of toxicity markers by ochratoxin A in rat hepatocytes primary culture and HK-2 cell line. Toxicology Letters (Shannon) 144(Suppl 1): s65
Kurzfeld-Zexer,L.; Wool,D.; Inbar,M. 2010: Modification of tree architecture by a gall-forming aphid. Trees: Structure And Function: 1, 13-18
Shaughnessy, K.H.; Western, E.C.; Gannett, P.M.; Daft, J.R.; Johnson, E.M. 2002: Modification of unprotected nucleosides using water-soluble palladium catalysts. Abstracts of Papers American Chemical Society 224(1-2): ORGN 649
Giannakopoulou, A.E.; Vyssoulis, G.P.; Toutouza, M.G.; Karpanou, E.A.; Belegrinos, D.A.; Economou, E.B.; Toutouzas, P.K. 2001: Modification of vascular endothelial function and haemostasis control with dihydropyridine treatment. American Journal of Hypertension 14(4 Part 2): 71A-72A
Ness, K.F.; Sharif, I.; Macpherson, S.; Gustaffson, J.A.; Saunders, P.; Gray, G.A. 2002: Modification of vascular function by the oestrogen receptor beta The effect of ageing. British Journal of Pharmacology 137(Proceedings Suppl): 5P
Worthington, J.; Murray, M.; O'rourke, M.; Keilty, G.; Hirst, D.G.; Robson, T. 2000: Modification of vascular tone using inducible nitric oxide synthase under the control of a radiation-inducible promoter. Cancer Gene Therapy 7(8): 1210
Fan, W.; Mclaughlin, B.J. 2001: Modification of vascular tube formation in co-cultures of retinal pigment epithelium and choroidal endothelium. IOVS Investigative Ophthalmology and Visual Science 42(4): S95
Stemmer, W.P.C.; Patten, P.; Soong, N.W.i 2003: Modification of virus tropism and host range by viral genome shuffling. Official Gazette of the United States Patent and Trademark Office Patents 1272(4)
Trese, M.T.; Williams, G.A.; Hartzer, M.; Dailey, W. 2004: Modification of vitreal matrix metalloproteinase activity. Official Gazette of the United States Patent and Trademark Office Patents 1286(1)
Picard, D.; Couturier, M.; Myhal, D.; Picard, M. 2000: Modification of women behaviours towards osteoporosis by a self-administered clinical risk assessment questionnaire and knowledge of their calcaneum bone density as measured by quantitative ultrasound. Journal of Bone and Mineral Research 15(Suppl 1): S288
Sung, W.L.; Yaguchi, M.; Ishikawa, K. 1999: Modification of xylanase to improve thermophilicity, alkophilicity and thermostability. Official Gazette of the United States Patent and Trademark Office Patents 1219(1): 497
Dynlacht, J.R.; Seno, J.D. 2000: Modification or translocation of DNA repair proteins as a mechanism of heat-radiosensitization. International Journal of Radiation Oncology Biology Physics 48(3 Suppl): 287-288
Collins, K.K.; Delucca, J.M.; Alexander, M.E.; Bevilacqua, L.M.; Berul, C.I.; Mayer, J.E.; Jonas, R.A.; Walsh, E.P.; Delnido, P.J.; Triedman, J.K. 2000: Modification to the Fontan procedure for prophylaxis against intra-atrial reentrant tachycardia A prospective randomized blinded study. Circulation 102(18): 2; 496-II 497
Ion Titapiccolo, G.; Corredig, M.; Alexander, M. 2010: Modification to the renneting functionality of casein micelles caused by nonionic surfactants. Journal of Dairy Science 93(2): 506-514
Beyer, E.C.; Berthoud, V.M.; Montegna, E.A.; Pal, J.D.; Ebihara, L. 1999: Modification, targeting, and assembly of connexin56 in stably transfected HeLa cells. IOVS Investigative Ophthalmology and Visual Science 40(4): S970
Walter, N.G.; Rueda, D.; Bokinsky, G.; Rhodes, M.M.; Zhuang, X. 2004: Modification-interference analysis of single RNA enzymes reveals effects on both folding and chemistry. Biophysical Journal 86(1): 144a
Elortza, F.; Foster, L.J.; Stensballe, A.; Jensen, O.N. 2004: Modification-specific proteomic strategy for identification of glycosyl-phosphatidylinositol anchored membrane proteins. Kamp, Roza Maria , Reprint Author, Calvete, Juan J, Choli-Papadopoulou, Theodora Methods in proteome and protein analysis: 67-79
Jensen, O.Nørregaard. 2004: Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. Current Opinion in Chemical Biology 8(1): 33-41
Panasyuk, O.A. 2002: Modificational methods of pre-operative intraarterial occlusion of blood vessels of tumors of different location. International Journal of Cancer Suppl (13): 284
Hamprecht, D.W.; Brown, M.J.B.; Hibbs, M.J.; Jarvest, R.L.; Mensah, L.; O'hanlon, P.J.; Pope, A.J.; Richardson, C.M. 2003: Modifications around the carboxylate group of the tryptophanyl tRNA synthetase inhibitor chuangxinmycin Active non-charged analogues and tight sterical constraints. Abstracts of Papers American Chemical Society 226(1-2): ORGN 553
Yang, D.; Kruszewski, S.; Bom, D.; Zimmer, S.G.; Pommier, Y.; Kohlhagen, G.; Bingcang, A.L.; Du, W.; Curran, D.P.; Burke, T.G. 2000: Modifications at the 10-position markedly impact on the physicochemical and pharmacological properties of the novel, highly lipophilic silatecan DB-67 and its 7- ethyl- analog. Proceedings of the American Association for Cancer Research 41: 655
Senger, S.; Elsner, J.; Kapp, A.; Koehl, J. 2002: Modifications at the N-terminus of C3a abolish its biologic function a study using the phage display technique. Journal of Allergy and Clinical Immunology 109(1 Suppl): S112
Wiedemann, J.M.; Foster, J.D.; Nordlie, R.C. 1999: Modifications by Ehrlich ascites tumors, in vivo, of the mouse hepatic glucose-6-phosphatase system. FASEB Journal 13(7): A1348
Derakhchan, K.; Vinet, A.; Cardinal, R. 1999: Modifications by d-Sotalol of electrical activity in the reentrant substrate of canine post-infarction ventricular tachycardias. Circulation 100(18): 1; 270
Danielli, B.; Scheggi, S.; Grappi, S.; Marchese, G.; De Montis, M.G.; Tagliamonte, A.; Gambarana, C. 2010: Modifications in DARPP-32 phosphorylation pattern after repeated palatable food consumption undergo rapid habituation in the nucleus accumbens shell of non-food-deprived rats. Journal of Neurochemistry 112(2): 531-541
Aune, G.J.; Sordet, O.; Furuta, T.; Antony, S.; Bohr, V.A.; Pommier, Y. 2003: Modifications in RNA polymerase II induced by ecteinascidin-743 are associated with the poisoning of transcription-coupled nucleotide excision repair. Proceedings of the American Association for Cancer Research 44: 310
Buyken, A.E.; Flood, V.; Rochtchina, E.; Nestel, P.; Brand-Miller, J.; Mitchell, P. 2010: Modifications in dietary fat quality are associated with changes in serum lipids of older adults independently of lipid medication. Journal of Nutrition 140(1): 88-94
Drapeau, V.; Despres, J.P.; Bouchard, C.; Tremblay, A. 2003: Modifications in food group consumption related to long-term body weight changes. International Journal of Obesity 27(Suppl 1): S130
Luca, M.G.; Cervellin, E.; Galeazzi, F.; Lanaro, D.; Busetto, L.; Pigozzo, S.; Basso, D.; Mastropaolo, G. 2001: Modifications in food intake, leptin and CCK postprandial levels after gastric banding for morbid obesity. Gastroenterology 120(5 Suppl 1): A 209
Zeleznik, A.J. 2000: Modifications in gonadotropin signaling A key to understanding ovarian cyclicity during the menstrual cycle. Biology of Reproduction 62(Suppl 1): 93
La Marca, A.; Morgante, G.; Torricelli, M.; Guidoni, C.; Facchini, C.; De Leo, V. 2000: Modifications in insulin-like growth factor binding protein I and IGF-I plasma levels during treatment with clomiphene citrate in women with polycystic ovary syndrome. Journal of Reproduction and Fertility Abstract Series 25: 89
Ruel, K.; Chabannes, M.; Pincon, G.; Piquemal, J.; Boudet, A.M.; Legrand, M.; Joseleau, J.P.ul 2000: Modifications in lignin biosynthesis pathways affect plant cell-wall assembly. Abstracts of Papers American Chemical Society 219(1-2): CELL 134
Marita, J.M.; Ralph, J.; Hatfield, R.D.; Guo, D.; Chen, F.; Dixon, R.A. 2002: Modifications in lignin of transgenic alfalfa downregulated in caffeic acid 3-O-methyltransferase and caffeoyl coenzyme A 3-O-methyltransferase. Plant Biology (Rockville) : 87
M.R.sano, G.; Leonardo, F.; Onorati, D.; Zoncu, S.; Sarais, C.; Mercuro, G. 2000: Modifications in lipid profile and endothelial function in response to low dose estrogen replacement therapy in menopausal women at risk for CAD. Circulation 102(18): 2; 706
Bonhomme, B.M.; Cia, D.; Azais Braesco, V.; Doly, M. 1999: Modifications in retinoids metabolism in RCS rat retinal pigment epithelial cells. IOVS Investigative Ophthalmology and Visual Science 40(4): S476
Moschakis,T.; Murray,B.S.; Biliaderis,C.G. 2010: Modifications in stability and structure of whey protein-coated o/w emulsions by interacting chitosan and gum arabic mixed dispersions. Food Hydrocolloids: 1, 8-17
Laven, B.A.; Alsikafi, N.F.; Yang, X.J.; Brendler, C.B. 2002: Modifications in surgical technique to further reduce the incidence of positive surgical margins in radical retropubic prostatectomy. Journal of Urology 167(4 Suppl): 354
Deliagina, T.G.; Orlovsky, G.N.; Selverston, A.I.; Arshavsky, Y.I. 1999: Modifications in the activity of postural control system in Clione related to different forms of behavior. Society for Neuroscience Abstracts 25(1-2): 2175
Cabral, C.A.; Sampaio, F.J.; Eloisio, S.A.; Cardoso, L.E. 2003: Modifications in the composition of urinary bladder extracellular matrix components associated with puberty or ooforectomy in female rats. Journal of Urology 169(4 Suppl): 271
Machwe, S.; Sapra, G.R. 2000: Modifications in the development of cell surface pattern in the unicellular protozoan Stylonychia lemnae. Cell Biology International 24(12): 934
Giger Reverdin, S.; Duvaux Ponter, C.; Morand Fehr, P.; Weill, P.; Sauvant, D. 2002: Modifications in the percentages of the C18 milk fatty acids due to the unsaturation level of dietary fats fed to dairy goats at the onset of lactation. Journal of Dairy Science 85(Suppl 1): 315-316
Gallego Delgado, J.; Lazaro, A.; Osende, J.; Vivanco, F.; Egido, J. 2004: Modifications in the proteome of hearts from spontaneously hypertensive rats treated with antihypertensive drugs. American Journal of Hypertension 17(5)
Boraud, T.; Bezard, E.; Bioulac, B.; Gross, C.E. 1999: Modifications induced in globus pallidus neuronal activity by passive limb movements in normal and MPTP-monkeys. Society for Neuroscience Abstracts 25(1-2): 332
Watson, R.M.; Avenant Oldewage, A. 2000: Modifications made to the parasite index developed as water quality monitoring tool in the Olifants River. Journal of the South African Veterinary Association 71(2)
Meisel, P.; Landgraf, K.F.; Schafer, J.; Thiel, W.; Rischer, M.; Olbrich, A.; Kutscher, B. 2003: Modifications of 2-amino-4- -1-ethoxycarbonylaminobenzene, and processes for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1268(4)
Trampczynska, A.; Gawronska, H.; Winska Krysiak, M.; Gawronski, S.W. 1999: Modifications of ABA level and methalotionein expression in Sinapis alba L in response to heavy metals. Acta Physiologiae Plantarum 21(3 Suppl): 78
Yang, S.J.; Jiang, M.; Ashamalla, H. 2001: Modifications of G2 arrest induced by genistein vs radiation. Proceedings of the American Association for Cancer Research 42: 90-91
Hertel, N.E.; Pfeifer, H.; Napolitano, D.G. 1999: Modifications of SKYSHINE-III to analyze interim spent fuel storage installations. Health Physics 76(6 Suppl): S106
Hinkle, D.J.; Bianchi, M.T.; Macdonald, R.L. 2003: Modifications of a commercial perfusion system for use in ultrafast solution exchange during patch clamp recording. Biotechniques 35(3): 472
Cross, M.; Kruspe, M.; Palombi, P.S.; Moorman, K. 2001: Modifications of a computer model of the auditory pathway. AAAS Annual Meeting and Science Innovation Exposition 167: A86, February 15-20
Wang, Y.long; Niemi, Jarmo; Airas, Kalervo; Ylihonko, Kristiina; Hakala, Juha; Mantsala, Pekka 2000: Modifications of aclacinomycin T by aclacinomycin methyl esterase and aclacinomycin-10-hydroxylase from Streptomyces purpurascens. Biochimica et Biophysica Acta 1480(1-2): 191-200, 14 July
Mitchell, W.B.; Li, J.; Fisher, E.A.; French, D.L. 2003: Modifications of aparagine-linked glycans mark the alphaIIb integrin subunit for endoplasmic reticulum-associated degradation A model for alphaIIbbeta3 quality control. Blood 102(11): 290a
Glowacki, F.; Kandoussi, A.; Duriez, P.; Hugues, V.; Hazzan, M.; Noel, C. 2001: Modifications of apolipoproteins C-III and -E distribution among apolipoprotein B containing lipoprotein particles in renal transplant recipients A long term survey. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 931A
van Boekel, M.A.M.; van Venrooij, W.J. 2003: Modifications of arginines and their role in autoimmunity. Autoimmunity Reviews 2(2): 57-62
Bolzonella, C.; Previato, A.; Giuliani, A.L.; Moretti, C.; Confalonieri, G.; Aloni, A.; Indelli, M.; Rigolin, F.; Reverberi, R.; Carmignoto, F.; Ferrazzi, E.; Berti, G. 2001: Modifications of erythrocyte complement receptor 1 in tumor patients. Tumori 87(6): S28
Happ, T.; Wittenzellner, R.; Ziegelaar, B.; Stoelzel, K.; Staudenmaier, R.; Rotter, N.; Naumann, A.; Berghaus, A. 2003: Modifications of fibrin glue and media for improvement of stability of cartilage constructs in tissue engineering of cartilage. Tissue Engineering 9(4): 825
Tanenbaum, S.W.; Boll, H.; Wen, H.H.; Perrotta, J.A.; Nakas, J.P.; Lai, Y.Z. 1999: Modifications of fungal laccases for biotechnology transfers. FASEB Journal 13(7): A1456
Cinelli, M.E.; Patla, A.E.; Racco, V. 2000: Modifications of gait velocity to avoid collisions. Archives of Physiology and Biochemistry 108(1-2): 84
Komuro, M.; Tsuchida, T.; Araki, I.; Takihana, Y.; Matsushita, K.; Takeda, M. 2003: Modifications of laparoscopic radical prostatectomy Extraperitoneal approach and identification of dissection plane at the bladder neck using simultaneous bi-planar transrectal ultrasonography. European Urology Suppls 2(1): 206
Naydun, S.N.; Demidchik, V.V. 2000: Modifications of plasmalemma ion channels under long-term cell exposure to high temperature. Biochemical Society Transactions 28(5): A393
Taitzoglou, I.A.; Kokoli, A.N.; Killian, G.J. 2007: Modifications of surface carbohydrates on bovine spermatozoa mediated by oviductal fluid: a flow cytometric study using lectins. International Journal of Andrology 30(2): 108-114
Bernardino Sgherri, J.; Dutrillaux, B. 2001: Modifications of the DNA methylation pattern of testicular cells during rodent spermatogenesis. Chromosome Research 9(Suppl 1): 29-30
Mctigue, M.A.; Pinko, C.; Parast, C.V.; Gehring, M.R.; Kan, C.C.; Appelt, K.; Wickersham, J.A.; Showalter, R.E.; Tempcyzk Russell, A.M.; Mroczkowski, B.; Villafranca, J.E. 2004: Modifications of the VEGF Receptor-2 Protein and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1285(5)
Trenz, K.; Witton Davies, T.; Speit, G. 2003: Modifications of the comet assay for an improved use in human biomonitoring. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R164
Mcfadyen, I.J.; Ho, J.C.; Mosberg, H.I.; Traynor, J.R. 2000: Modifications of the cyclic mu receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]NH2 (Et): effects on opioid receptor binding and activation. Journal of Peptide Research: Official Journal of the American Peptide Society 55(3): 255-261
Ristovski, M.; Jovanovski, M.; Kostadinova, S. 2000: Modifications of the direct and indirect immunofluorescence technique in the diagnosis of the bullous dermatoses. Pathology International 50(Suppl): A58
Domey, N.D.; Atkinson, A.J. 2000: Modifications of the fugacity-based STP model for new substances exposure assessment in Canada. Canadian Technical Report of Fisheries and Aquatic Sciences 2331: 106
D.P.ula, J.A.; Spinelli, E.; Dubin, A.; Davolos, J. 2001: Modifications of the redox potential of the intestinal lumen during intestinal ischemia in rats. Gastroenterology 120(5 Suppl 1): A 196
Stahl, M. 2000: Modifications of the scoring function in FlexX for virtual screening applications. Perspectives in Drug Discovery and Design 20: 83-98
Hily, C.; Bouteille, M. 1999: Modifications of the specific diversity and feeding guilds in an intertidal sediment colonized by an eelgrass meadow. Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie 322(12): 1121-1131
Lopez Barba, J.; Perez Ramos, S.; Rodriguez Iglesias, M. 2001: Modifications of the susceptibility pattern to fluorquinolones in Gram negative rods isolated from clinical samples Experience of 5 years. International Journal of Antimicrobial Agents 17(Suppl 1): S161
Ladenheim, B.D.; Mast, J. 2000: Modifications of the sweep-VEP Fast, slow and long. IOVS Investigative Ophthalmology and Visual Science 41(4): S624
Escapa,I.H.; Axsmith,B.J.; Taylor,T.N.; Taylor,E.L. 2010: Modifications of the transfer technique for studying complex plant structures. Review of Palaeobotany And Palynology 9: 1 2, 62-68
Tari, I.; Szalai, G.; Csiszar, J.; Janda, T.; Balint, A.; Szegletes, Z.; Erdei, L. 2000: Modifications of thiol contents, glutathione reductase and glutathione S-transferase activities in wheat varieties with different sensitivities to copper. Plant Physiology and Biochemistry (Paris) 38(Suppl): s203
Saranteas, T.; Zotos, N.; Lolis, E.; Stranomiti, J.; Mourouzis, C.; Chantzi, C.; Tesseromatis, C. 2003: Modifications of various metabolic pathways following ketamine anesthesia in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R30
Cook, I.H.; Tozer, G.M. 2001: Modifications to endothelial tubulin by nitric oxide Response to microtubule-depolymerising agent, combretastatin A-4-PCS parkins. British Journal of Cancer 85(Suppl 1): 33
Alemany, R.; Suzuki, K.; Curiel, D.T. 2000: Modifications to improve the efficacy of replicative adenoviral vectors. Cancer Gene Therapy 7(8): 1206-1207
Shalhav, A.L.; Stevens, L.H.; Gardner, T.A.; Koch, M.O.; Lingeman, J.E. 2001: Modifications to improve the learning curve outcomes for laparoscopic donor nephrectomy. Journal of Endourology 15(Suppl 1): A102
Broadhurst, M.K. 2000: Modifications to reduce bycatch in prawn trawls A review and framework for development. Reviews in Fish Biology and Fisheries 10(1): 27-60
Fegan, R.L.; Long, K.; Wall, D.; Regan, D.; Alonso, J.M.; Johnson, C.; Lasky, L.C. 1999: Modifications to the processing of cord blood to increase cell recoveries. Transfusion 39(10 Suppl): 15S
Palmer, M.J.; Luethi, A.; Isaac, J.T.R.; Benke, T.A.; Collingridge, G.L. 1999: Modificiation of AMPA receptor conductance as an expression mechanism for depotentiation in the rat hippocampus in vitro. Journal of Physiology (Cambridge) 515P: 54P-55P
Kim, J.M.; Fung, D.Y.C. 1999: Modified 1-2 test system for isolation and identification of Listeria monocytogenes. Abstracts of the General Meeting of the American Society for Microbiology 99: 512
Conney, A.H. 2002: Modified 2-Alkoxyestradiol derivatives with prolonged pharmacological activity. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)
Heams, T.; Kupiec, J.-J. 2003: Modified 3'-end amplification PCR for gene expression analysis in single cells. Biotechniques 34(4): 712
Haeberle, O.; Xu, C.; Dieterlen, A.; Jacquey, S. 2001: Modified 4Pi microscope with a resolution near 100 nm and a long working distance. Biology of the Cell 93(3-4): 251
Biggart, S.; Redwood, S.; Webb Peploe, M. 1999: Modified AHA/ACC lesion classification Effect on fractional flow reserve in patients with single vessel coronary artery disease. Journal of the American College of Cardiology 33(2 Suppl A): 99A
Bose, A.K.; Ing, Y.H.; Pramanik, B.N.; Bhattacharjee, A.; Sharma, A.H. 2001: Modified Akabori reaction for sequence determination of peptides derivatized at the N-terminus. Abstracts of Papers American Chemical Society 221(1-2): ORGN 284
Igarashi, R.; Mizushima, Y.; Taiji, M.; Nakayama, C.; Noguchi, H. 2004: Modified BDNF. Official Gazette of the United States Patent and Trademark Office Patents 1287(1)
Maiden, N.; Uhlfelder, R.L.qmani M.; Stone, J. 2000: Modified BVAS for Wegeners granulomatosis. Clinical and Experimental Immunology 120(Suppl 1): 69
Merlo, D.J.; Folkerts, O. 2000: Modified Bacillus thuringiensis gene for lepidopteran control in plants. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)
Cornelissen, M.; Soetaert, P.; Stam, M.; Dockx, J.; Van Aarssen, R. 1999: Modified Bacillus thuringiensis genes with improved expression in plant cells, methods of production on and use. Official Gazette of the United States Patent and Trademark Office Patents 1226(2)
Kovaru, F.; Kovaru, H.; Fiserova, A.; Matalova, E.; Mares, V.; Lisa, V.; Palikova, M. 2000: Modified C6 glioma cells as targets in model NK cytotoxicity reactions. European Journal of Neuroscience 12(Suppl 11): 361
Miyagawa, S.; Okabe, M. 2004: Modified CRE recombinase gene for mammals. Official Gazette of the United States Patent and Trademark Office Patents 1282(2)
Huang, J.; Ge, X.; Sun, M. 2000: Modified CTAB protocol using a silica matrix for isolation of plant genomic DNA. Biotechniques 28(3): 432; 434
Mearini, E.; Mearini, L.; Zucchi, A.; Porena, M. 2000: Modified Camey II technique. European Urology 37(Suppl 2): 141
Markau, U.; Ebenbichler, C.; Achhammer, G.; Ankenbauer, W. 2002: Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction. Official Gazette of the United States Patent and Trademark Office Patents 1259(1)
Creasy, D.M.; Jonassen, H.; Lucacel, C.; Agajanov, T.; Gondek, H.; Schoenfeld, H. 2003: Modified Davidsons fixative as an alternative to Bouins for evaluation of fetal soft tissue anomalies using the Wilsons serial sectioning technique. Toxicologic Pathology 31(Suppl): 147
Kwon, S.C.; Jung, S.Y.; Shin, H.; Choi, J.D.; Choi, K.D.; Lee, G.S. 2003: Modified E coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous protein. Official Gazette of the United States Patent and Trademark Office Patents 1273(2)
Karapetis, C.S.; Yip, D.; Lo, S.K.; Benepal, T.; Cowling, M.; Harper, P.G. 1999: Modified ECF in the treatment of advanced oesophago-gastric cancer - An active regimen without the need for central venous catheter mediated therapy. British Journal of Cancer 80(Suppl 2): 58
Ozturk, M.; Barista, I.; Altundag, M.; Turker, A.; Yalcin, S.; Kars, A.; Gullu, I.; Guler, N.; Ozisik, Y.; Tekuzman, G. 2001: Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkins lymphoma Experience at Hacettepe University and a review of the literature. European Journal of Cancer 37(Suppl 6): S94
Berkner, K.L.; Petersen, L.C.; Hart, C.E.; Hedner, U.; Bregengaard, C. 2000: Modified Factor VII. Official Gazette of the United States Patent and Trademark Office Patents 1232(3)
Wang, S.; Thottathil, J.K. 2000: Modified Fischer indole synthesis of acid-labile indoles and avitriptan, a potent 5-HT1D receptor agonist. Abstracts of Papers American Chemical Society 219(1-2): ORGN 210
Earing, M.G.; O'leary, P.W.; Dearani, J.A.; Puga, F.J.; Danielson, G.K.; Mair, D.D. 2003: Modified Fontan operation for double inlet left ventricle Improving survival and long term outcome in 225 patients. Circulation 108(17): IV609
Paul, T.; Ernemann, H.; Bertram, H.; Heinemann, M.; Kaulitz, R.; Luhmer, I.; Hecker, H.; Ziemer, G. 1999: Modified Fontan operation with autologous atrial tissue Reduced incidence of postoperative atrial dysrhythmias during medium term follow-up. Journal of the American College of Cardiology 33(2 Suppl A): 540A
Youngberg, G.; Giorgadze, T.; Joyce, L.; Walker, S. 2001: Modified Fontana-Masson stain for fungal differential diagnosis. Laboratory Investigation 81(1): 187A
Kobilka, B.; Lee, T.W.on 2002: Modified G protein sunbunits. Official Gazette of the United States Patent and Trademark Office Patents 1262(2)
Wang, Z.; Martinez, J.; Zhou, W.; La Rosa, C.; Srivastava, T.; Dasgupta, A.; Rawal, R.; Li, Z.; Britt, W.J.; Diamond, D. 2010: Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines. Vaccine 28(6): 1547-1557
Berzofsky, J.A.; Pendleton, C.D.; Feinstone, S.M.; Major, M.E.; Sarobe, P. 2004: Modified HCV peptide vaccines. Official Gazette of the United States Patent and Trademark Office Patents 1279(1)
Leach, D.R.; Sonderbye, L.K.; Renard, V.; Gregorius, K.; Birk, P.; Gautam, A.; Mouritsen, S. 2002: Modified HER-2 DNA and protein vaccines for immunotherapy of HER-2 overexpressing tumors. Proceedings of the American Association for Cancer Research 43: 609
Zimmerman, D.H.; Sarin, P.S. 2000: Modified HGP-30 heteroconjugates, compositions and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1237(3)
Zimmerman, D.H.; Sarin, P.S. 2001: Modified HGP-30 peptides, conjugates, compositions and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1248(5)
Davis, H.F.; Skolasky, R.; Selnes, O.; Burgess, D.; Mcarthur, J.C. 2000: Modified HIV dementia scale and Grooved Pegboard Accurate staging of HIV-associated dementia. Journal of Neurovirology 6(3): 246
Kang, C.Y. 1999: Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1247
Goldman, S.; Robinson, P.; Lee, J.E.S. 1999: Modified HPLC method for the quantitation of total homocysteine. Clinical Chemistry 45(6 Part 2): A147
Li, S.; Koller, E.; Speiser, W.; Pangerl, T.; Novotny, C.; Valent, P.; Dudczak, R.; Virgolini, I. 2000: Modified LDL increases the binding of 125I-vascular endothelial growth factor165 to human monocytes and arterial endothelial cells. Journal of Nuclear Medicine 41(5 Suppl): 172P
Song, W.; Luberto, C.; Lyons, T. 2003: Modified LDL stimulation of PKC translocation in human retinal pericytes. Diabetes 52(Suppl 1): A203
Chen, L.H.; Meade, H. 2003: Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)
Maroof, M.; Ahmed, M.; Khan, R.M.; Huda, W.; Chabra, J.; Varshney, A. 2002: Modified Mallampatti technique correlates better with Cormack and Lehanes grades of laryngoscopic view. Anesthesia and Analgesia 94(2S Suppl): S 130
Moran, R.H.; Ohls, R.K.; Holmes, G. 2003: Modified McGoon index ltoreq13 does not predict mortality in infants with congenital diaphragmatic hernia. Pediatric Research 53(4 Part 2): 496A
Cristofano, C.; Gallucci, M.; Vernaglione, L.; Gigante, B.; Chimienti, S. 2001: Modified Mediterranean diet and ketoacids supplementation impact on chronic renal failure. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 374A
Cristofano, C.; Gallucci, M.; Vernaglione, L.; Gigante, B.; Chimienti, S. 2001: Modified Mediterranean diet impact on chronic renal failure. Nephrology Dialysis Transplantation 16(6): A99
Parks, C.L. 2003: Modified Morbillivirus V proteins. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)
Poirier, N.C.; Drummond Webb, J.J.; Imamura, M.; Harrison, A.M.; Mee, R.B.B. 2000: Modified Norwood procedure using a high flow cardiopulmonary bypass strategy results in low mortality without late arch obstruction. Canadian Journal of Cardiology 16(Suppl F): 222F
Oliff, A.I.; Edwards, G.M.; Jones, D.D. 2001: Modified PE40 toxin fusion proteins. Official Gazette of the United States Patent and Trademark Office Patents 1244(4)
Kiss, G.; Rehder, P.; Madersbacher, H. 2002: Modified PNE-testing with permanent electrodes gives better results. European Urology Suppls 1(1): 143
Achim, C.; Popescu, D.L.; Franzini, R.; Patra, G.K. 2003: Modified Peptide Nucleic Acids as scaffold for transition metal ions. Abstracts of Papers American Chemical Society 226(1-2): INOR 493
Prochaska, S.C. 2001: Modified Relay Intercropping. Ohio Journal of Science 101(1): A 25
Protogerou, V.; Albanis, S.; Dellis, A.; Liakouras, C.; Moschou, M.; Antoniou, N.; Deliveliotis, C. 2004: Modified S-pouch neobladder versus ileal conduit and a matched control population A Quality of Life survey. Journal of Urology 171(4 Suppl): 40
Gold, L.; Zichi, D.A.; Smith, J.D.ew 2002: Modified SELEX processes without purified protein. Official Gazette of the United States Patent and Trademark Office Patents 1257(4)
Gatti, R.A. 2002: Modified SSCP method using sequential electrophoresis of multiple nucleic acid segments. Official Gazette of the United States Patent and Trademark Office Patents 1263(1)
Swinkels, H.L.; Laan, R.F.; van 't Hof, M.A.; van der Heijde, D.M.; de Vries, N.; van Riel, P.L. 2001: Modified sharp method: factors influencing reproducibility and variability. Seminars in Arthritis and Rheumatism 31(3): 176-190
Stutzman Engwall, K.J.; Price, B.S. 2004: Modified Streptomyces host cells for increased avermectin production and methods of making the same. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)
Sheiban, Imad; Marsico, Federica; Pagnotta, Paolo; Montorfano, Matteo; Anzuini, Angelo; Rosano, Giuseppe; Saba, Piersergio; Di Mario, Carlo; Colombo, Antonio; Chierchia, Sergio L. 1999: Modified T stenting technique for kissing stents in bifurcational coronary lesions Clinical feasibility and immediate angiographic results. Journal of the American College of Cardiology 33(2 Suppl A): 69A
Smyth, A.P.; Robinson, G.S. 2003: Modified VEGF Oligonucleotides for Inhibition of tumor growth. Official Gazette of the United States Patent and Trademark Office Patents 1276(3)
Robinson, G.S. 2002: Modified VEGF oligonucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1259(1)
Lane, S.S.; Lehmann, R.P.; Stewart, R.H.; Robertson, S.M.; Gower, L.A. 2001: Modified VEXOL is more effective in treating ocular inflammation following cataract surgery. IOVS Investigative Ophthalmology and Visual Science 42(4): S6
Sharpe, S.; Polyanskaya, N.; Leech, S.; Sutter, G.; Cranage, M. 1999: Modified Vaccinia Ankara constructs expressing SIV genes stimulate an early CTL response in vaccinated macaques. Journal of Medical Primatology 28(4-5): 304
Spiethoff, A.; Nuesse, T.; Koser, M.; Bohrer, M.H. 2003: Modified WHO-classification of papillary superficial bladder cancer and correlation to DNA ploidy and follow-up data. Pathology Research and Practice 199(4): 198
Marzabadi, C.H.; Franck, R.W. 1999: Modified acyloin glycosides from bicylic carbohydrate donors. Abstracts of Papers American Chemical Society 217(1-2): CARB 47
Carter, B.J.; Flotte, T.; Afione, S.; Solow, R. 1999: Modified adeno-associated virus vector capable of expression from a novel promoter. Official Gazette of the United States Patent and Trademark Office Patents 1219(1): 592
Legrand, V.; Mehtali, M.; Boulanger, P. 2003: Modified adenoviral fiber and target adenoviruses. Official Gazette of the United States Patent and Trademark Office Patents 1270(4)
Van Raaij, M.J.; Cusack, S.; Legrand, V.; Leissner, P.; Mehtali, M. 2004: Modified adenoviral fibre and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1282(4)
Krasnykh, V.N.; Curiel, D.T. 2004: Modified adenovirus containing a fiber replacement protein. Official Gazette of the United States Patent and Trademark Office Patents 1288(2)
Wood, A.G. 2004: Modified adhesive gauze. Official Gazette of the United States Patent and Trademark Office Patents 1288(1)
Li, G.P.; Bunch, T.D. 2004: Modified air-dry method reveals that diploid cells are predominant in cloned bovine embryos. Reproduction Fertility and Development 16(1-2): 148-149
Reish, O.; Mashevitz, M.; Gobazov, R.; Rosenblat, M.; Sher, C.; Libman, V.; Avivi, L. 2003: Modified allelic replication in genomes of patients with Beckwith Wiedemann Syndrome. American Journal of Human Genetics 73(5): 227
Srivastava, O.; Szweda, R. 1999: Modified alpha-D-Glcrho- -alpha-D-Glcrho- -alpha-D-Glcrho-ana ogues. Official Gazette of the United States Patent and Trademark Office Patents 1224(4)
Leone Bay, A.; Ho, K.K.; Press, J.B.; Wang, N.F. 2000: Modified amino acids and compositions comprising the same for delivering active agents. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)
Guha, N.; Boyd, C.A.R.; Meredith, D. 1999: Modified amino acids and peptides as inhibitors of the rabbit peptide transporter PepT1 expressed in Xenopus laevis oocytes. Journal of Physiology (Cambridge) 517P: 27P-28P
Leone Bay, A.; Wang, N.F.ng 2001: Modified amino acids for drug delivery. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)
Rudolf, K.; Eberlein, W.; Engel, W.; Pieper, H.; Doods, H.; Hallermayer, G.; Entzeroth, M.; Wienen, W. 2002: Modified aminoacids, pharmaceuticals containing these compounds and method for their production. Official Gazette of the United States Patent and Trademark Office Patents 1255(1)
De, D.; Krogstad, F.M.; Byers, L.D.; Krogstad, D.J. 2000: Modified aminoquinolines with a terminal piperidine on the diaminoalkane side chain. Abstracts of Papers American Chemical Society 219(1-2): MEDI 1
Uhlmann, E.; Peyman, A.; Will, D.W.; Chang, E.; Pirollo, K.; Rait, A. 2004: Modified antisense nucleotides complementary to a section of the human Ha-ras gene. Official Gazette of the United States Patent and Trademark Office Patents 1281(3)
Sakuma, H.; Yamamoto, M.;mi 1999: Modified apoptosis regulation by glucose involved in the glucose-inducd induced atherosclerosis development. Diabetes 48(Suppl 1): A136
Ghavamian, R.; Zincke, H. 1999: Modified approach to nerve sparing radical retropubic prostatectomy results in optimal continence and a marked decrease in postoperative bladder neck contracture rate. Journal of Urology 161(4 Suppl): 396
Julian, G.R.; Jaynes, J.M. 1999: Modified arginine containing lytic peptides and method of making the same by glyoxylation. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)
Clark, M.A. 2001: Modified arginine deiminase. Official Gazette of the United States Patent and Trademark Office Patents 1243(1)
Day, H.J.; Blakeney, E.W. 2003: Modified assay for chitin deacetylase. Abstracts of Papers American Chemical Society 225(1-2): CHED 923
Johanning, G.L.; Lu, D.; Wang Johanning, F. 2001: Modified assays for evaluation of HPV 16 E6 and E7 mRNA expression in cervical tissues. Proceedings of the American Association for Cancer Research 42: 51
Jelinkova, L.; Paulus, W.E.; Strehler, E.; Zhang; Sterzik, K. 2001: Modified assisted hatching applied to two-pronuclear stage embryos. Human Reproduction 16(Abstract Book 1): 116
Besmann, T.M.; Kulkarni, N.; Spear, K.E.; Vienna, J.D. 2003: Modified associate species thermochemical model of high-level nuclear waste glass compositions. Abstracts of Papers American Chemical Society 226(1-2): NUCL 102
Delduca, G.R.; Deyo, A.E.; Luthra, V.K.; Wu, W.P. 1999: Modified atmosphere package. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)
Rocha, A.M.C.N.; Barreiro, M.G.; Morais, A.M.M.B. 2004: Modified atmosphere package for apple Bravo de Esmolfe. Food Control 15(1): 61-64
Carr, D.G.; Castner, G.C.; Delduca, G.R.; Demay, R.H.; Deyo, A.E.; Goulette, S.L.; Hansen, D.P.; Luthra, V.K.; Norby, A.J.; Sloan, R.A.; Thompson, J.F. 2000: Modified atmosphere package with accelerated reduction of oxygen level in meat compartment. Official Gazette of the United States Patent and Trademark Office Patents 1233(4)
Sandhya 2010: Modified atmosphere packaging of fresh produce current status and future needs. Lwt: 3, 381-392
Kennedy, C.; Kerry, J.P.; Buckley, D.J. 2000: Modified atmosphere packaging of lamb Effect of meat volume to package headspace ratio on shelf-life quality. Irish Journal of Agricultural and Food Research 39(3): 472
Rosebrough, S.F. 2002: Modified avidin and streptavidin and methods of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1261(1)
Bayer, E.A.; Wilchek, M.; Morag, E. 1999: Modified avidin and streptavidin molecules and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1227(4)
Schechter, B.; Arnon, R.; Wilchek, M. 2003: Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system. Official Gazette of the United States Patent and Trademark Office Patents 1275(4)
Boulain, J.C.; Cattolico, L.; Ducancel, F.; Menez, A. 1999: Modified bacterial alkaline phosphatases and their applications. Official Gazette of the United States Patent and Trademark Office Patents 1221(1)
Ishihara, M.; Yamanaka, S. 2003: Modified bacterial cellulose. Official Gazette of the United States Patent and Trademark Office Patents 1274(5)
Hammock, Richard Dale 2000: Modified barium swallow board. Official Gazette of the United States Patent and Trademark Office Patents 1231(5)
Irwin, S.W.B.; Galaktionov, K.V.; Mccarthy, H.O.; Fitzpatrick, S.M. 2000: Modified behaviour of periwinkles infected by pygmaeus group microphallid digeneans in arctic and temperate regions. Acta Parasitologica 45(3): 173
Chang, Tse Wen 2001: Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)
Chang, Tse Wen 2000: Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)
Lappas, A.; Bienert, H.; Bernd, T.; Kirchhof, B. 1999: Modified biodegradable polymer films as carrier for transplantation of iris pigment epithelial cells. IOVS Investigative Ophthalmology and Visual Science 40(4): S938
Campbell, Anthony Keith 2002: Modified bioluminescent proteins and their use. Official Gazette of the United States Patent and Trademark Office Patents 1261(4)
Runt, J.; Weisberg, D.M.; Xu, R.; Garrett, J.T.; Manias, E.; Benesi, A.; Gordon, B.; Snyder, A.J.; Rosenberg, G. 2001: Modified biomedical poly block copolymers Nanocomposites and polyisobutylene comb polymers. Abstracts of Papers American Chemical Society 222(1-2): POLY 48
Chauhan, S.; Magann, E.; Field, K.; Chanding, F.; Moreno, F.; Klausen, J. 2002: Modified biophysical profile with amniotic fluid index versus single deepest pocket A randomized clinical Trial. American Journal of Obstetrics and Gynecology 187(6 Suppl): S145
Oxley, J.; Startari, J.F.ancis 2001: Modified bioreactor. Official Gazette of the United States Patent and Trademark Office Patents 1242(3)
Story, R.; Nannapaneni, R.; Johnson, M.G. 1999: Modified blood agar medium for microcolony detection of Campylobacter jejuni and C coli within 36 h. Abstracts of the General Meeting of the American Society for Microbiology 99: 513
Clodfelter, C.B.; Mathes, T.E.; Sprick, W.D.uglas 2004: Modified bottle neck for use with child resistant caps. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)
Savage, C.; Zwischenberger, J.B.; Donald, D.J.; Dongfong, W.; Heming, T.A.; Schmalstieg, F.C.; Bidani, A. 2000: Modified bronchoalveolar lavage improves macrophage harvest in acute respiratory distress syndrome. Chest 118(4 Suppl): 157S
Caro, C.; Doorly, D. 1999: Modified cannula. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)
Kondo, K.; Chin, K.; Sakamoto, J.; Kojima, H.; Terashima, M.; Yamamura, Y.; Tsujinaka, T.; Hyodo, I. 2003: Modified capecitabine regimen for advanced/metastatic gastric cancer Final results from a multicenter phase II Trial. EJC Suppls 1(5): S69
Strother, T.C.; Smith, L.M.; Hamers, R.J. 2003: Modified carbon, silicon, germanium surfaces. Official Gazette of the United States Patent and Trademark Office Patents 1270(4)
Mortensen, Uffe; Olesen, Kjeld; Stennicke, Henning; S.O.SlashedRensen, Steen B.; Breddam, Klaus 1999: Modified carboxypeptidase. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)
Begent, R.H.J.; Chester, K.; Minton, N.P.; Rees, A.R.; Sharma, S.K.; Spencer, D.I.R. 2003: Modified carboxypeptidase enzymes and their use. Official Gazette of the United States Patent and Trademark Office Patents 1277(1)
Musa, R.; Bilzi, R.; Ventura, P.; Chiesi, P. 2003: Modified carrier particles for use in dry powder inhalers. Official Gazette of the United States Patent and Trademark Office Patents 1276(1)
Masuda, T. 2002: Modified cellulose triacetate membranes. Contributions to Nephrology 137: 106-110
Rossi, G.; Zecca, M.; Marchi, A.; de Stefano, P.; Sammarchi, L.; Locatelli, F. 2003: Modified chop-chemotherapy plus rituximab for diffuse large b-cell lymphoma complicating ataxia-telangiectasia. British Journal of Haematology 120(2): 369-371
Wiegand, S.J.; Sleeman, M.W.; Lambert, P.D. 2004: Modified ciliary neurotrophic factor, method of making and methods of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1278(3)
Chen, Y.; Deng, L. 2002: Modified cinchona alkaloid catalyzed parallel kinetic resolutions of monosubstituted succinic anhydrides. Abstracts of Papers American Chemical Society 224(1-2): ORGN 823
He, S.; Blombäck, M.; Yoo, G.; Sinha, R.; Henschen-Edman, A.H. 2001: Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system. Annals of the new York Academy of Sciences 936: 531-535
Chmielewska, J.; Lundqvist, T.; Masialou, E.; Ogg, D. 2000: Modified coagulation agent. Official Gazette of the United States Patent and Trademark Office Patents 1234(5)
Hourcade, D.E.; Oglesby, T.J. 1999: Modified complement proteases. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1623
Molloy, E.J.; O'neill, A.J.; Sheridan Pereira, M.; Fitzpatrick, J.M.; Watson, R.W.; Webb, D.W. 2002: Modified cord blood neutrophil survival and function may explain increased neonatal susceptibility to infection. Pediatric Research 51(4 Part 2): 309A
Kilman, S. 1999: Modified corn seed hurt butterfly in test. Wall Street Journal 233(98): B2
Duman, G.; Koylu, D.; Kolodzie, M.; Taralp, A. 2003: Modified cotton bearing potential anti-microbial and blood-clotting activity. Abstracts of Papers American Chemical Society 225(1-2): CELL 70
Smith, W.K.; Church, K.E.; Taylor, J.S.; Rusch, D.H.; Gipson, P.S. 2001: Modified decoy trapping of male ring-necked pheasant and northern bobwhite. Game and Wildlife Science 18(3-4): 581-586
Tolchanov, A.; Choumakov, P.; Kadiev, R.; Tatarkyn, A. 2002: Modified detrusorrhaphy for repair of unilateral vesicoureteral reflux. European Urology Suppls 1(1): 163
Mattano, L.A.; Sather, H.N.; La, M.K.; Nachman, J.B.; Seibel, N.L. 2003: Modified dexamethasone reduces the incidence of treatment-related osteonecrosis in children and adolescents with higher risk acute lymphoblastic leukemia A report of CCG-1961. Blood 102(11): 221a-222a
Regazzoni, C.; Winterhalter, K.H.; Rohrer, L. 1999: Modified differential display technique to generate long cDNA fragments within the coding region. Analytical Biochemistry 269(1): 192-194
Sword, C.J.; Constantinou, A.A.; Collier, I.D.; Bailey, P.D.; Boyd, C.A.R. 2000: Modified dipeptides inhibit substrate uptake into PepT1-expressing Xenopus oocytes. Journal of Physiology (Cambridge) 528P: 99P-100P
Mera, R. 2003: Modified direct adjustment of S Pneumoniae penicillin resistance rates. American Journal of Epidemiology 157(11 Suppl): S101
Roser, Bruce Joseph 2001: Modified disposable injector device. Official Gazette of the United States Patent and Trademark Office Patents 1246(1)
Iberico, G.; Serra, V.; Rodriguez, M.; Simon, C.; Pellicer, A.; Remohi, J. 2000: Modified early transvaginal technique of embryo reduction in multifetal pregnancies resulting from assisted reproduction techniques. Human Reproduction 15(Abstract Book 1): 142-143
Davidson, J.C.; Balch, J.W. 2001: Modified electrokinetic sample injection method in chromatography and electrophoresis analysis. Official Gazette of the United States Patent and Trademark Office Patents 1252(3)
Haynes, C.; Erlwein, O.; Schnierle, B.S. 2003: Modified envelope glycoproteins to retarget retroviral vectors. Current Gene Therapy 3(5): 405-410
Jones, J.Bryan 2002: Modified enzymes and their use for peptide synthesis. Official Gazette of the United States Patent and Trademark Office Patents 1258(4)
Von Der Osten, C.; Olsen, A.A.; Roggen, E.L. 2003: Modified enzymes having polymer conjugates. Official Gazette of the United States Patent and Trademark Office Patents 1274(4)
Hirai, Y.; Koshida, S.; Oka, Y. 2000: Modified epimorphin. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)
Arora, R.R.; Orlando, J.; Senanan, O.; Gerula, C.; Spillert, C.R. 2002: Modified erythrocyte sedimentation rate. FASEB Journal 16(4): A133
Bittman, R.; Erukulla, R.K.; Peters, A.C.; Mayhew, E.G. 2003: Modified ether glyceroglycolipids. Official Gazette of the United States Patent and Trademark Office Patents 1271(1)
Imbert, C.; Rodier, M.H.; Daniault, G.; Jacquemin, J.L. 2001: Modified expression and secretion of the 95 kDa metallopeptidase of Candida albicans following growth in subinhibitory or inhibitory concentrations of fluconazole, itraconazole and 5-fluorocytosine. Mycoses 44(Suppl 1): 33
Sarto, C.; Favini, P.; Valsecchi, C.; Casellato, S.; Magni, F.; Musi, G.; Carmignani, L.F.; Ferrero, S.; Rocco, F.; Mocarelli, P. 2004: Modified expression of heat shock protein 27 in renal cell carcinoma. Journal of Urology 171(4 Suppl): 203
Cheng, D.W.; He, S.; Armstrong, K.C. 2003: Modified expression of two receptor kinase genes in hexaploid oat on inoculation with crown rust. Physiological and Molecular Plant Pathology 61(5): 281-288
Villers, A.; Stamey, T.; Yemoto, C.; Mcneal, E.J.; Rischmann, P. 2001: Modified extrafascial radical retropubic prostatectomy technique decreases frequency of positive surgical margins in T2 cancers 2 cc. Journal of Urology 165(5 Suppl): 329
Lollar, J.S. 2002: Modified factor VIII. Official Gazette of the United States Patent and Trademark Office Patents 1257(4)
Lollar, J.S. 2004: Modified factor VIII. Official Gazette of the United States Patent and Trademark Office Patents 1285(1)
Negrier, C.; Plantier, J.L.c 2004: Modified factor VIII cDNA. Official Gazette of the United States Patent and Trademark Office Patents 1287(1)
Negrier, C.; Plantier, J.L.c 2004: Modified factor VIII cDNA and its use for the production of factor VIII. Official Gazette of the United States Patent and Trademark Office Patents 1285(4)
Weaver, J.; Tsai, P.; Cao, G.L.; Roman, L.J.; Rosen, G.M. 2003: Modified ferricytochrome c cannot be used to estimate nitric oxide synthase generation of superoxide. Analytical Biochemistry 320(1): 141-143
Kataoka, H.; Kiyohara, S. 2001: Modified fish oil type material containing highly unsaturated fatty acid and/or esters thereof, and a composition containing said material. Official Gazette of the United States Patent and Trademark Office Patents 1246(4)
Ahrndt, P.; Petersen, H.B.; Chang, V.H.; Allen, K.A.; Cain, M.H. 1999: Modified form of the R -N- but-3-enyl-nipecotic acid hydrochloride. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)
Vadas, M.A.; Lopez, A.F.; Shannon, M.F. 1999: Modified forms of granulocyte macrophage-colony stimulating factor as antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1225(3)
Wittekind, M.; Weinheimer, S.; Zhang, Y.; Goldfarb, V. 2004: Modified forms of hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of proteaseinhibitor complexes. Official Gazette of the United States Patent and Trademark Office Patents 1287(1)
Lai, C.S.; Wang, T. 2002: Modified forms of pharmacologically active agents and uses therefor. Official Gazette of the United States Patent and Trademark Office Patents 1261(1)
Lutsenko, S.V.; Kiselev, S.M.; Feldman, N.B.; Zabolotnev, D.V.; Severin, S.E. 2002: Modified forms of the EGF receptor-binding fragment as an efficient vehicle for targeted drug delivery to tumor cells. Tumor Biology 23(Suppl 1): 68
Baumann, M.; Appold, S.; Zips, D.; Nestle, U.; Petersen, C.; Herrmann, T. 2000: Modified fractionation in the radical treatment of non-small-cell lung cancer. Feldmann, H Journal Author, Kneschaurek, P Author, Molls, M Author Frontiers of Radiation Therapy and Oncology Three-dimensional radiation treatment: Technological innovations and clinical results 80-88
Fournier, A.; Letourneau, M. 2000: Modified fragments of endothelin active in an ET-A receptor bioassay. Regulatory Peptides 94(1-3): 46, 25 October
Bird, C.R.; Holt, K.A.; Picard, S.; Schuch, W.W.; Carey, A.T.; Seymour, G.B.; Tucker, G.A. 1999: Modified fruit containing galactanase transgene. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1440
Kloti, A.S. 2001: Modified full length promoters. Official Gazette of the United States Patent and Trademark Office Patents 1253(3)
Zaitseva, N.V.; Ulanova, T.S.; Nurislamova, T.V.; Karnazhitskaya, T.D.; Popova, N.A. 1999: Modified gas chromatographic determination of butyl alcohol, acrylic acid, and butyl ester of acrylic acid in the ambient air and air of working space. Gigiena i Sanitariia 1999(2): 74-75
Eichholtz, D.A.; Gasser, C.S.; Kishore, G.M. 2001: Modified gene encoding glyphosate-tolerant 5-enolpruvyl-3-phosphoshikimate synthase. Official Gazette of the United States Patent and Trademark Office Patents 1246(1)
Sode, K. 2000: Modified glucose dehydrogenase. Official Gazette of the United States Patent and Trademark Office Patents 1237(3)
Falorni, A.; Lernmark, A.; Robertson, J.; Essen Moller, A. 2000: Modified glutamic acid decarboxylase. Official Gazette of the United States Patent and Trademark Office Patents 1236(4)
Tsien, R.Y.; Heim, R. 2000: Modified green fluorescent proteins. Official Gazette of the United States Patent and Trademark Office Patents 1234(4)
Westlund, R.W.; Peterfeso, R.M.; Hinders, M.N.; Tockman, B.A.; Greenland, J.S. 2002: Modified guidewire for left ventricular access lead. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)
Ward, F.M. 2000: Modified gum arabic and guar gum systems as emulsifying and stabilizing agents. Abstracts of Papers American Chemical Society 220(Part 1): CARB 80
Trimble, S.P.; Mathews, A.J.; Kerwin, B.A.; Marquardt, D.A.; Anthony Cahill, S.; Epp, J.K.; Madril, D.G.; Anderson, D.C. 2000: Modified hemoglobin-like compounds and methods of purifying same. Official Gazette of the United States Patent and Trademark Office Patents 1240(3)
Baldwin, A.L.; Valeski, J.E. 2003: Modified hemoglobins increase migration of eosinophils into intestinal villus lamina propria. FASEB Journal 17(4-5): Abstract 346
Berlin, K.D.; Brown, C.W.; Benbrook, D.M. 2001: Modified heteroarotinoids-anticancer activity. Abstracts of Papers American Chemical Society 221(1-2): MEDI 307
Moyle, M.; Foster, D.L. 1999: Modified hookworm neutrophil inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)
Harrison, R.A.; Farries, T.C. 2001: Modified human C3 DNA sequences and vectors. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)
Cascieri, M.A.; Macneil, D.J.; Strader, C.D. 1999: Modified human neuropeptide Y1 Receptors. Official Gazette of the United States Patent and Trademark Office Patents 1229(2)
Milstein, S.J.; Barantsevitch, E.N. 1999: Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1227(4)
Hardt, E.; Fritsche, A.; Stefan, N.; Schuetzenauer, S.; Haering, H.U.; Stumvoll, M. 1999: Modified hyperglycaemic clamp designed to detect defects in glucose, incretin and arginine induced insulin secretion. Diabetologia 42(Suppl 1): A79
Rudowitsch, N.N.; Dick, D.; Nauck, M.A.; Schatz, H.; Pfeiffer, A.F.H. 2000: Modified hyperglycemic clamp to detect phenotypic marker of genetic defects leading to type 2 diabetes. Diabetologia 43(Suppl 1): A142
Petzoldt, R.; Petrounkina, A.M.; Waberski, D.; Weitze, K.F.; Toepfer Petersen, E. 1999: Modified hypoosmotic swelling test for boar sperm Correlation with the vital staining. Reproduction in Domestic Animals 34(1): 43
Minetti, C.; Michon, F.; Pullen, J.K.; Polvino Bodnar, M.E.; Liang, S.M.; Tai, J.Y. 2004: Modified immunogenic pneumolysin compositions as vaccines. Official Gazette of the United States Patent and Trademark Office Patents 1284(3)
Morrison, S.L.; Chintalacharuvu, K.R.; Yoo, E.M.; Trinh, K.M.; Coloma, M.J. 2001: Modified immunoglobin molecules and methods for use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1250(1)
Bogen, B.; Sandlie, I.; Fossum, S.; Mjaaland, S.; Lunde, E.; Rasmussen, I.B. 2001: Modified immunoglobulin molecule incorporating an antigen in a non-CDR loop region. Official Gazette of the United States Patent and Trademark Office Patents 1250(4)
Nanci, A.; Mckee, M.D. 1999: Modified implant with bioactive conjugates on its surface for improved integration. Official Gazette of the United States Patent and Trademark Office Patents 1220(1): 337
Pestka, S. 2001: Modified interferons. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)
Talanian, R.V.; Mankovich, J.A.; Ghayur, T.; Ferenz, C.R. 1999: Modified interleukin-1beta converting enzyme with increased stability. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1532
Swaminathan, S.; Matteucci, M.D.; Pudlo, J.; Jones, R.J. 2002: Modified internucleoside linkages. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)
Werblin, T. 2002: Modified intraocular lens and method of correcting optical aberrations therein. Official Gazette of the United States Patent and Trademark Office Patents 1260(1)
Li, Z.H.; Liu, D.P.; Liang, C.C. 1999: Modified inverse PCR method for cloning the flanking sequences from human cell pools. Biotechniques 27(4): 660-662
Mehrotra, P.K.; Srinivasan, K.R.; Srivastava, A.; Pathak, R.; Kitchlu, S.; Misra, A.P.; Raj, K. 2003: Modified iridoid glycosides and monosugars as anti adhesive-cum-anti implantation agents Effect on uterine epithelial cells in-vitro and implantation in-utero. Medicinal Chemistry Research 12(6-7): 291
Picard, C.; Linard, C.; Wysocki, J.; Fioramonti, J.; Griffiths, N.M. 1999: Modified jejunal and colonic motility following abdominal irradiation in the rat. Gastroenterology 116(4 Part 2): A1064
Srivastava, O.; Szweda, R.; Spohr, U. 1999: Modified kojibioside analogues. Official Gazette of the United States Patent and Trademark Office Patents 1220(1): 531
Klingler, H.; Remzi, M.; Janetschek, G.; Marberger, J. 2003: Modified laparoscopic nephroureterectomy for treatment of TCC of the upper urinary tract to avoid tumour seeding. European Urology Suppls 2(1): 100
Bernardo, Norberto O.; De La Torre, German C.; Hajek, David; Rizzi, Alfredo O.; Mazza, Osvaldo N.; Liatsikos, Evangelos N. 2001: Modified laparoscopic scissors A new tool for making the incision during endopyelotomy. Journal of Urology 165(5 Suppl): 18
Cartledge, R.; Lane, J. 2003: Modified laryngoscope blade to reduce dental injuries during intubation. Official Gazette of the United States Patent and Trademark Office Patents 1274(4)
Gage, F.H.; Suhr, S.T. 2001: Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)
Neri, D.; Winter, G.P.ul 2001: Modified ligands of calcium-dependent binding proteins. Official Gazette of the United States Patent and Trademark Office Patents 1252(2)
Huntley, S.K.; Ellis, D.; Gilbert, M.; Chapple, C.; Mansfield, S.D. 2002: Modified lignin Its role in fibre processibility and fibre quality. Abstracts of Papers American Chemical Society 223(1-2): CELL 101
Sima, A.; Stancu, C. 2002: Modified lipoproteins accumulate in human coronary atheroma. Journal of Cellular and Molecular Medicine 6(1): 110-111
Haug, C.; Schmid Kotsas, A.; Zorn, U.; Gruenert, A.; Bachem, M.G. 2002: Modified lipoproteins reduce hepatocyte growth factor synthesis in human coronary artery smooth muscle cells. European Heart Journal 23(Abstract Suppl): 125
Ramakrishnan, S.; Moeller, P.W. 2003: Modified liquid smoke flavors. Abstracts of Papers American Chemical Society 226(1-2): AGFD 31
Ritchie, B.W.; Lukert, P.D.; Pesti, D. 1999: Modified live avian polymavirus vaccine in psittacine birds. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)
Hernández-Martínez, G.; Castillo, M.L. 2003: Modified Logs as a Means for Rearing and Observing Sapwood/Heartwood Dwelling Passalids (Coleoptera: Passalidae) in the Laboratory. The Coleopterists Bulletin 57(2): 243-244
Phakdeekitcharoen, B.; Watnick, T.; Germino, G. 1999: Modified long-range PCR approach for mutation detection of exons 2-34 of PKD1 in archived DNA samples. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 423A-424A
Sawamura, T.; Masaki, T. 2001: Modified low density lipoprotein receptor. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)
Weitz, J.I.; Hirsh, J. 2000: Modified low molecular weight heparin that inhibits clot associated coagulation factors. Official Gazette of the United States Patent and Trademark Office Patents 1235(2)
Velarde, V.; Jenkins, A.A.; Christopher, J.T.; Lyons, T.J.; Mayfield, R.K.; Jaffa, A.A. 1999: Modified low-density lipoproteins activate MAPK via a protein kinase C, src kinase, and calcium/calmodulin-dependent pathway in vascular smooth muscle cells. Diabetes 48(Suppl 1): A125
Kopser, S.J.; Mays, W.A.; Lockwood, S.K.; Knilans, T.K.; Claytor, R.P.; Shore, S. 2001: Modified maximal cycle ergometry test protocol for patients with univentricular heart after Fontan palliation. Medicine and Science in Sports and Exercise 33(5 Suppl): S30
Yulaev, M.F.; Dmitrieva, N.M.; Abdullaeva, M.N.; Askarov, K.A.; Shodieva, F.A.; Usmonova, M.F. 2000: Modified method for measuring blood fibrinolytic activity. Klinicheskaya Laboratornaya Diagnostika 5: 33-34
Ikramov, A.; Nurmatov, S.; Akhmedova, D.; Nuritdinov, A.; Mukhamedov, R.; Atakhodjaev, S. 2003: Modified method of differential lysis for mixed biomaterials after sexual assaults. Forensic Science International 136(Suppl 1): 31-32
Olazaran, M.G.; Saldana, H.B.; Salvado, J.M. Viader 2002: Modified methylotrophic Pichia pastoris yeast which secretes human growth hormone. Official Gazette of the United States Patent and Trademark Office Patents 1254(5)
Bergeron, N.; Thibault, K.; Jacques, H.; Gascon, A.; Arul, J.; Bergeron, J. 1999: Modified milk fat reduces postprandial lipemia in healthy men compared to regular milk fat and non-hydrogenated margarine. FASEB Journal 13(4 Part 1): A231
Jacques, H.; Asselin, G.; Lavigne, C.; Arul, J.; Angers, P. 2002: Modified milk fats with different high melting points alter fecal fat content and composition in guinea pigs. FASEB Journal 16(5): A986-A987
Belford, D.A.; Rogers, M.L.; Regester, G.O.; Smithers, G.W.; Ballard, F.J.; Francis, G.L. 2001: Modified milk growth factor. Official Gazette of the United States Patent and Trademark Office Patents 1243(4)
Mawatari, K.; Shibahara, S.; Ueda, T.; Takeuchi, M.; Shimotori, K. 2002: Modified milk powder composition. Official Gazette of the United States Patent and Trademark Office Patents 1260(4)
Kloti, A.S. 2002: Modified minimal promoters. Official Gazette of the United States Patent and Trademark Office Patents 1257(4)
Khosla, C.; Ashley, G.W.; Fu, H.; Kao, C.M.; Mcdaniel, R. 2002: Modified modular PKS with retained scaffold. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)
Xia, J.H.; Stewart, D.; Kermode, A.R. 2002: Modified moist chilling treatments that promote germination and post-germinative reserve mobilization of different seed lots of yellow-cedar Spach. Seed Science and Technology 30(2): 263-277
Mitrovic, D.; Mitrovic, S.; Todorovic, V.; Nedeljkovic, N.; Gligorovic, V. 2000: Modified morphological platelet score Original parameter for quality control of stored platelet concentrates. Vox Sanguinis 78(Suppl 1): P654
Jovine, E.; Masetti, M.; Cautero, N.; Di Benedetto, F.; Gelmini, R.; Sassi, S.; Quintini, C.; Andreotti, A.; Begliomini, B.; Siniscalchi, A.; Pinna, A.D. 2002: Modified multivisceral transplantation without a liver graft for Gardner/Desmoid syndrome and chronic intestinal pseudo-obstruction. Transplantation Proceedings 34(3): 911-912
Basova, G.M.; Popova, T.A.; Skopintseva, V.L.; Chubirko, M.I. 2001: Modified mycotoxin study procedure. Gigiena i Sanitariia 3: 71-72
Parales, R.; Gibson, D.; Resnick, S.; Lee, K. 2004: Modified naphthalene dioxygenases and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1286(3)
Murakami, M.; Nakagawasai, O.; Hozumi, S.; Tan No, K.; Umemiya, M.; Nunoki, K.; Yanagisawa, T.; Yanai, K.; Watanabe, T.; Tadano, T.; Kisara, K. 2000: Modified nociception in mice lacking the beta3 subunit of the voltage-dependent calcium channel. Japanese Journal of Pharmacology 82(Suppl 1): 138P
Economides, A.; Stahl, N.E.; Harland, R.M. 2000: Modified noggin polypeptide and compositions. Official Gazette of the United States Patent and Trademark Office Patents 1235(2)
Kornienko, E.A.; Dmitrienko, M.A.; Klochko, O.G.; Nazhiganov, O.N.; Mamayev, N.A.; Grigoriev, S.V. 2003: Modified noninvasive ammonia breath test for Helicobacter pylori. Helicobacter 8(4): 456
Brocard, J.B.; Chambon, P.H.; Gronemeyer, H.; Metzger, D.; Nicolas, J.C.; Roux, S. 2004: Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)
Will, Stephen Gordon 1999: Modified nucleic acid amplification primers. Official Gazette of the United States Patent and Trademark Office Patents 1229(2)
Weston, A.; Assenberg, R.; Marsh, P.; Mock, G.A.; Ray, T.D.; Wharam, S.D.; Cardy, D.L.N. 2002: Modified nucleic acid probes and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)
Rajeev, K.G.; Maier, M.A.; Manoharan, M. 2001: Modified nucleobase containing peptide nucleic acids. Abstracts of Papers American Chemical Society 222(1-2): CARB15
Shirokova, E.A.; Shipitsin, A.V.; Victorova, L.S.; Dyatkina, N.B.; Goryunova, L.E.; Beabealashvilli, R.S.; Hamilton, C.J.; Roberts, S.M.; Krayevsky, A.A. 1999: Modified nucleoside 5'-triphosphonates as a new type of antiviral agents. Nucleosides and Nucleotides 18(4-5): 1027-1028
Chowdhury, A.R.; Held, H.; Benner, S.A. 2001: Modified nucleosides Metal catalyst mediated insertion of thio fuctionality in pyrimidines. Abstracts of Papers American Chemical Society 221(1-2): ORGN 121
Kloti, A.S. 2002: Modified nucleotide sequence encoding a LexA DNA binding domain optimized for arabidopsis species. Official Gazette of the United States Patent and Trademark Office Patents 1259(1)
Short, J.M. 2003: Modified nucleotides and methods useful for nucleic acid sequencing. Official Gazette of the United States Patent and Trademark Office Patents 1271(3)
Hansa, J.; Hibbs, A.; Salisbury, D. 2002: Modified oat and corn grit products and method. Official Gazette of the United States Patent and Trademark Office Patents 1263(5)
Manoharan, M.; Cook, P.D.; Guinosso, C.J. 2003: Modified oligonucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1276(4)
Cociorva, O.M.; Lowary, T.L. 2001: Modified oligosaccharides as inhibitors of mycobacterial arabinan biosynthesis. Abstracts of Papers American Chemical Society 222(1-2): CARB73
Ramneantu, O.M.; Lowary, T.L. 2000: Modified oligosaccharides as inhibitors of mycobacterial arabinosyltransferases. Abstracts of Papers American Chemical Society 220(Part 1): CARB 52
Stetinova, V.; Herout, V.; Kvetina, J. 2003: Modified one-generation reproduction study of ursodeoxycholic acid in rats and its subchronic toxicity in the F1 offspring. Toxicology Letters (Shannon) 144(Suppl 1): s109
Willett, T.A.; Meyer, A.L.; Steere, A.C.; Huber, B.T. 2000: Modified outer surface protein-A as a second generation vaccine against Lyme disease. FASEB Journal 14(6): A1104
Halazonetis, T.D.; Stavridi, E.S. 2002: Modified p53 tetramerization domains having hydrophobic amino acid substitutions. Official Gazette of the United States Patent and Trademark Office Patents 1258(2)
Frazer, I.; Zhou, J. 1999: Modified papilloma virus L2 protein and VLPs formed therefrom. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)
Martinez,N.A.; Schneider,R.J.; Messina,G.A.; Raba,J. 2010: Modified paramagnetic beads in a microfluidic system for the determination of ethinylestradiol in river water samples. Biosensors and Bioelectronics: 6, 1376-1381
Platt, D.; Chang, Y. 2002: Modified pectin and nucleic acid composition. Official Gazette of the United States Patent and Trademark Office Patents 1265(5)
Busin, M. 2004: Modified penetrating keratoplasty method. Official Gazette of the United States Patent and Trademark Office Patents 1286(2)
Simon, R.J.; Bartlett, P.A.; Santi, D.V. 1999: Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such. Official Gazette of the United States Patent and Trademark Office Patents 1227(2)
Feige, U.; Liu, C.F. 2003: Modified peptides as therapeutic agents. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)
Rodrigues, A.; Fonseca, I.; Santos, M.; Bravo, F.; Cabrita, A. 2002: Modified peritoneal equilibration test with 425%/386% dextrose solution Evaluation of peritoneal transport, sodium balance and CA125 appearance rate. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 595A
Cubicciotti, R.S. 2002: Modified phycobilisomes and uses therefore. Official Gazette of the United States Patent and Trademark Office Patents 1254(5)
Takahara, Y.; Sato, H.; Hayashi, E.; Yatagai, M.; Suzuki, M.; Tabata, T.; Ejima, C. 2003: Modified physiologically active proteins and medicinal compositions containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1274(3)
Kostrewa, D.; Pasamontes, L.; Tomschy, A.; Van Loon, A.P.G.M.; Vogel, K.W.; Wyss, M. 2002: Modified phytases. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)
Lomonossoff, G.P.; Johnson, J.E. 1999: Modified plant viruses as vectors. Official Gazette of the United States Patent and Trademark Office Patents 1219(4): 3267-3268
Lomonossoff, George Peter 1999: Modified plant viruses as vectors of heterologous peptides. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)
Dawson, K.M.; Gilbert, R.J. 1999: Modified plasmin precursors with resistance to inhibitors of plasmin. Official Gazette of the United States Patent and Trademark Office Patents 1225(1)
Gupta, S.K.; Singh, J.P.l 1999: Modified platelet factor-4. Official Gazette of the United States Patent and Trademark Office Patents 1225(2)
Afrasiabi, Z.; Muller, H.; Muller, T.; Paschke, R.; Paetz, C.; Sinn, E.; Sorkau, E. 2002: Modified platinum drugs Various carriers for drug transmission and targeting. Abstracts of Papers American Chemical Society 224(1-2): MEDI 71
Roseeuw, E.; Schacht, E.H.; Paesen, B. 2001: Modified poly as carrier for macromolecular prodrugs. Journal of Controlled Release 72(1-3): 257
Kataoka, K.; Kato, M.; Nagasaki, Y.; Ito, H.; Tsuruta, T.; Sakurai, Y.; Okano, T.; Suzuki, K. 2001: Modified polymers containing poly acrylate segment in the molecule. Official Gazette of the United States Patent and Trademark Office Patents 1250(4)
Von Der Osten, C.; Olsen, A.A.; Roggen, E.L. 2001: Modified polypeptide. Official Gazette of the United States Patent and Trademark Office Patents 1247(2)
Fasel, N.J.; Reymond, C.D. 2000: Modified polypeptides for enhanced immunogenicity. Official Gazette of the United States Patent and Trademark Office Patents 1238(1)
Sytkowski, A.J. 1999: Modified polypeptides with altered biological activity. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)
Weisgerber, D.J.; Rubingh, D.N. 2001: Modified polypeptides with high activity and reduced allergenicity. Official Gazette of the United States Patent and Trademark Office Patents 1250(1)
Marciani, D.J. 2003: Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1271(1)
Hedlund, B.E.; Weber, T.P.; Dragsten, P.R.; Hanson, G.J.; Hallaway, P.E. 2002: Modified polysaccharides exhibiting altered biological recognition. Official Gazette of the United States Patent and Trademark Office Patents 1264(2)
Lee, Y.S.; Ryoo, S.J. 2002: Modified polystyrene spherical, resin and process for decontaminating waste water by using the same. Official Gazette of the United States Patent and Trademark Office Patents 1257(2)
Ferrante, A.; Poulos, A.; Easton, C.J.; Pitt, M.J.; Robertson, T.A.; Rathjen, D.A. 2002: Modified polyunsaturated fatty acids. Official Gazette of the United States Patent and Trademark Office Patents 1257(4)
Camiener, G.W. 1999: Modified porphyroproteins. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1526
Kyle, Donald James 2002: Modified position bradykinin antagonist peptides. Official Gazette of the United States Patent and Trademark Office Patents 1263(1)
Akinci, O.F.; Düzgün, S.A.; Bozer, M.; Coskun, A.; Uzunköy, A. 1999: Modified posterior preperitoneal mesh hernioplasty for repair of inguinal hernia. European Journal of Surgery 165(5): 500-501
Shen, B.; Lashner, B.; Achkar, J.P.; Connor, J.T.; Ormsby, A.H.; Remzi, F.H.; Brzezinski, A.; Bevins, C.L.; Fazio, V. 2002: Modified pouchitis disease activity index A new approach to the diagnosis of pouchitis. Gastroenterology 122(4 Suppl 1): A 78
Johnson, M.D. 2000: Modified primer extension reactions for polynucleotide sequence detection. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)
Marchesi, J.R.; Weightman, A.J. 2000: Modified primers facilitate rapid screening of 16S rRNA gene libraries. Biotechniques 29(1): 48-50
Constantinou, M.; Shah, F.; Steel, C.J.; Poole, K.G.; Waters, S.L.; Marino, P.S.; Rhodes, C.G.; Moore, A.; Ind, P.I.; Luthra, S.K. 2002: Modified procedure for the radiosynthesis of 18F-fluticasone propionate for lung deposition studies in asthmatics using PET. Journal of Nuclear Medicine 43(5 Suppl): 136P-137P
Doyle, T.W.; Karra, S.; Li, Z.; Lin, X.; Mao, J.; Qiao, Q.; Xu, Y. 2002: Modified prodrug forms of AP/AMP. Official Gazette of the United States Patent and Trademark Office Patents 1263(1)
Cleuziat, P.; Guillou Bonnici, F.; Levasseur, P.; Mallet, F. 1999: Modified promoter for RNA polymerase, its preparation and its applications. Official Gazette of the United States Patent and Trademark Office Patents 1221(1)
Olsen, A.A.; Prento, A. 2002: Modified protease having 5 to 13 covalently coupled polymeric molecules for skin care. Official Gazette of the United States Patent and Trademark Office Patents 1260(2)
Von Der Osten, C.; Halkier, T.; Andersen, C.; Bauditz, P.; Hansen, P.K.mp 2001: Modified protease having improved autoproteolytic stability. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)
Chang, K.-A.; Luk, H.-N.; Jawan, B.; Lu, H.-F.; Chen, H.-S.; Chen, C.-L. 2004: Modified protective suits for anesthesiologists performing tracheal intubation for severe acute respiratory syndrome patients in Taiwan. Anesthesiology 100(6): 1630-1631
Kaibuchi, K.; Ono, Y.; Iwamatsu, A. 2003: Modified protein derived from protein kinase N. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)
Hentges, E. 2001: Modified protein diets. Journal of Dairy Science 84(Suppl 1): 139
Takahara, Y.; Yamada, N.; Motoki, M. 2000: Modified protein for gene transfer and process for producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1230(2)
Agrawal, S. 2003: Modified protein kinase A-specific oligonucleotides and methods of their use. Official Gazette of the United States Patent and Trademark Office Patents 1274(4)
Agrawal, S. 1999: Modified protein kinase a-specific oligonucleotide. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)
Kim, M.S.; Lee, S.G.; Kang, B.Y.; Lee, D.C. 2002: Modified protein, method for preparation thereof and compositions for external application containing the modified protein. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)
Atkinson, H.J.; Mcpherson, M.J.; Urwin, P.E. 2004: Modified proteinase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1278(3)
Jansen, R.W.; Meijer, D.K.F.; Molema, G.; De, C., E.D.A.; Pauwels, R.W.J.; Schols, D. 1999: Modified proteins and their use for controlling viral infections. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1575-1576
Khaja, M.N.; Poduri, C.D.; Habibullah, C.M. 2003: Modified protocol for hepatitis B virus DNA isolation and detection. Analytical Biochemistry 314(1): 142-143
Srienc, F.; Jackson, J.K.; Somers, D.A. 2000: Modified pseudomonas oleovorans phaC1 nucleic acids encoding bispecific polyhydroxyalkanoate polymerase. Official Gazette of the United States Patent and Trademark Office Patents 1240(1)
Jarjanazi, H.; Ozcelik, H. 2002: Modified rapid expansion detection method to analyze Cag/CTG repeat expansions. Biotechniques 32(5): 1006; 1008, 1010
Flyer, D.C.; Clary, K.W. 2001: Modified rapid expansion methods for in vitro propagation of T lymphocytes. Official Gazette of the United States Patent and Trademark Office Patents 1252(2)
Cohen, P. 2000: Modified rapid method for determination of cosmetic preservative efficacy. Abstracts of the General Meeting of the American Society for Microbiology 100: 410
Kohen, L.; Enzmann, V.; Hollborn, M.; Wiedemann, P. 2001: Modified reactivity of telomerase-immortalized RPE cells in vitro. IOVS Investigative Ophthalmology and Visual Science 42(4): S761
Beutler, B.A.; Bazzoni, F.M. 1999: Modified receptors that continuously signal. Official Gazette of the United States Patent and Trademark Office Patents 1224(3)
Bitensky, M.W.; Yoshida, T. 2003: Modified red blood cell that has surface molecules that neutralize chemical agents. Official Gazette of the United States Patent and Trademark Office Patents 1266(2)
Badalyan, G.K.; Galstyan, A.S.; Geokchyan, A.K. 2003: Modified regimens of chemotherapy in the process of Hodgkins disease in children. Leukemia 17(3): 684
Andersen, T.M.; Hjorth, T.B.; Jorgensen, K.W. 2001: Modified release formulations containing -1- -1propyl-3-pipe ridinecarboxylic acid. Official Gazette of the United States Patent and Trademark Office Patents 1244(4)
Lemmens, J.M.; Van Den Heuvel, D.J.M.; Platteeuw, J.J.; Van Dalen, F. 2003: Modified release formulations containing a hypnotic agent. Official Gazette of the United States Patent and Trademark Office Patents 1275(4)
Arora, J.; Jain, G.; Sen, H. 1999: Modified release matrix formulation of cefaclor and cephalexin. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)
Skinhoj, A.; Bertelsen, P. 2003: Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances. Official Gazette of the United States Patent and Trademark Office Patents 1272(5)
Skinhoj, A. 2000: Modified release multiple-units dosage composition for release of opioid compounds. Official Gazette of the United States Patent and Trademark Office Patents 1241(2)
Jepsen, S.K.; Halskov, S.O.SlashedRen 1999: Modified release oral pharmaceutical composition and method for the treatment of bowel diseases. Official Gazette of the United States Patent and Trademark Office Patents 1229(3)
Conley, C.P.; Roush, J.A.; Storm, K.H. 2003: Modified release pharmaceutical formulation comprising amoxycillin. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)
Schnickel, G.T.; Whiting, D.; Ross, D.; Belperio, J.; Levine, M.; Shpiner, R.; Laks, H.; Beygui, R.; Ardehali, A. 2004: Modified reperfusion in non-standard donor lungs. Journal of Heart and Lung Transplantation 23(2S): S89-S90
Beach, D.; Hannon, G.J. 2000: Modified retroviral vectors. Official Gazette of the United States Patent and Trademark Office Patents 1231(3)
Ledbetter, J.A.; Hayden, M.; Fell, P.; Mittler, R.; Winberg, G. 2004: Modified sFv molecules which mediate adhesion between cells and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)
Kolb, H.C.; Kanamarlapudi, R.C.; Richardson, P.F.; Khan, G. 2004: Modified safe and efficient process for the environmentally friendly synthesis of imidoesters. Official Gazette of the United States Patent and Trademark Office Patents 1287(3)
Vijay, P.S.; Vyas, S.J.; Sharma, S.; Deshpande, R.K. 2002: Modified scoring for risk factor analysis and its correlation with surgical procedures for carcinoma esophagus. International Journal of Cancer Suppl (13): 293-294
Kimura, F.; Kondoh, N.; Asano, T.; Hayakawa, M.; Yamamoto, M. 2003: Modified serial analysis of gene expression transcript profiles of renal cell carcinoma. Journal of Urology 169(4 Suppl): 149
Kozhevnikov, A.D. 2002: Modified serum albumin in the pathogenesis of glomerular diseases: a new hypothesis. Archives of Internal Medicine 162(3): 356-358
Carter, D.C. 2004: Modified serum albumin with reduced affinity for nickel and copper. Official Gazette of the United States Patent and Trademark Office Patents 1286(1)
Venot, A.P.; Nikrad, P.V.; Kashem, M.A. 1999: Modified sialyl Lewis-A compounds. Official Gazette of the United States Patent and Trademark Office Patents 1220(3): 2512-2513
Zelisko, P.M.; Brook, M.A. 2001: Modified silicones for the stabilization of proteins and enzymes in emulsions Potential vaccine delivery systems. Abstracts of Papers American Chemical Society 222(1-2): POLY 403
Zalazar, F.; Baroni, M.R.; Amato, D.; Gianni, R.; Mayoral, C.; Ochoteco, C.; Tedeschi, F. 2001: Modified silver staining for RNA and DNA in agarose gels. Analytical Biochemistry 291(2): 299-300
Neulander, E.Z.; Rivera, I.; Eisenbraun, N.; Wajsman, Z. 2001: Modified simple cystectomy in patients requiring urinary diversion. European Urology 39(Suppl 5): 72
Souza, P.M.; Fernandez, A.; Lopez-Carballo, G.; Gavara, R.; Hernandez-Munoz, P. 2010: Modified sodium caseinate films as releasing carriers of lysozyme. Food Hydrocolloids: 4, 300-306
Sun, X.; Bian, K. 2002: Modified soy protein adhesives. Official Gazette of the United States Patent and Trademark Office Patents 1265(4)
Saez, V.; Corrales, R.M.; Calonge, M.; Herreras, J.M.; Diebold, Y. 2001: Modified staining protocol enables light microscopy evaluation of conjunctival impression cytology samples collected by polyethersulfone filter paper. IOVS Investigative Ophthalmology and Visual Science 42(4): S487
Gilleland, G.M.; Turner, J.L.; Patton, P.A.; Harrison, M.D. 2002: Modified starch as a replacement for gelatin in soft gel films and capsules. Official Gazette of the United States Patent and Trademark Office Patents 1257(4)
Scott, R.A.; Cade, D.; He, X. 2003: Modified starch film compositions. Official Gazette of the United States Patent and Trademark Office Patents 1275(3)
Kossmann, J.; Springer, F.; Buttcher, V. 2003: Modified starch from plants, plants synthesizing the same, as well as process for their production. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)
Kossmann, J.; Springer, F.; Buttcher, V. 2000: Modified starch from plants, plants synthesizing this starch, and processes for its preparation. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)
Stemmer, W.P.C.; Subramanian, V.; Raillard, S.A.; Huisman, G. 2004: Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes. Official Gazette of the United States Patent and Trademark Office Patents 1280(2)
Melby, A.L.; Gunther, M.; Gaffney, T.W.; Matz, G.F. 2002: Modified starch solutions and their use in personal care. Official Gazette of the United States Patent and Trademark Office Patents 1257(1)
Wright, C.; Llanos, G.H.; Rakos, R.; King, K. 2001: Modified stent useful for delivery of drugs along stent strut. Official Gazette of the United States Patent and Trademark Office Patents 1249(2)
Grebenok, R.; Stilb, B.; Williams, B.; Battista, P. 2001: Modified sterol levels alter growth and development in transgenic tobacco. Plant Biology (Rockville) : 107
Zafar, A. 2001: Modified stripper for varicose vein surgery. Tropical Doctor 31(4): 215-216
Bailey, K.; Gabbert, H.; Lammersfeld, C.; Marsh, I.; Megna, J.; Revemont, V.; Vashi, P. 2000: Modified subjective global assessment , an effective tool for implementing nutrition support in oncology patients. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1065
Aaslyng, D.; Branner, S.; Hastrup, S.; Norskov Lauritsen, L.; Olsen, O.H.; Simonsen, M.; Casteleijn, E.; Egmond, M.R.; Haverkamp, J.; Marugg, J.D.; Mooren, A.T. Anthonius 2001: Modified subtilisins and detergent compositions containing same. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)
Rawls, H.Ralph 2000: Modified surfaces resistant to bacterial colonization. Official Gazette of the United States Patent and Trademark Office Patents 1230(4)
Macleod, C. 1999: Modified surgical glove and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)
Mueller, A.R.; Pascher, A.; Platz, K.P.; Nüssler, N.C.; Schulz, R.J.; Horch, D.; Melitz, T.; Sauer, I.M.; Eisele, R.; Settmacher, U.; Dignass, A.; Lopez-Henninen, E.; Weidemann, H.; Neuhaus, P. 2002: Modified surgical technique in clinical small bowel transplantation: donor and recipient management. Transplantation Proceedings 34(6): 2265-2267
Liu, H.; Kvamme, C.; Smoliakova, I. 2003: Modified synthesis of exo-glucal from methyl alpha-D-glucopyranoside. Abstracts of Papers American Chemical Society 225(1-2): CHED 486
Meller, B.; Bahre, B.; Richter, E. 1999: Modified synthesis of fluoromisonidazole for clinical pet. Journal of Nuclear Medicine 40(5 Suppl): 150P
Dilley, D.R.; Kadyrzhanova, D.K.; Wang, Z.; Warner, T.M. 2001: Modified synthetases to produce penicillins and cephalosporins under the control of bicarbonate. Official Gazette of the United States Patent and Trademark Office Patents 1250(1)
O'quinn, P.R.; Owen, K.Q.; Nelssen, J.L.; Tokach, M.; Goodband, R.D. 2000: Modified tall oil supplemented diet for growing-finishing pigs. Official Gazette of the United States Patent and Trademark Office Patents 1231(1)
Kubac, P.; Burzova, R. 2001: Modified technique of Sternheimer cytodiagnostic stain for urine sediment. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S386
Lopez Iglesias, M.; Ornelas Ponce, R.; Mondragon Mendoza, J.C.; Guzman Guzman, A. 2001: Modified technique of anterior colporrhaphy 10-year evaluation of results. Obstetrics and Gynecology 97(4 Suppl): 49S
Chin, J.L.; Mcfarlane, N.; Izawa, J.; Pautler, S. 2000: Modified technique of apical dissection during radical retropubic prostatectomy. Journal of Urology 163(4 Suppl): 356
Loverro, G.; Greco, P.; Cormio, G.; Vimercati, A.; Marello, F.; Selvaggi, L. 2000: Modified technique of transabdominal cerclage in cervical pregnancy. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 20(1): 82-83
Abouljoud, M.S.; Brown, K.A.; Moonka, D.K.; Shick, L.; Escobar, F.; Douzdjian, V. 2000: Modified technique reduces hepatic artery complications after liver transplantation. Hepatology 32(4 Pt 2): 241A
Byron, C.R.; Benson, B.M.; Karlin, W.M.; Stewart, A.A. 2010: Modified tenoscopic method for carpal flexor retinaculum release in a horse. Veterinary Surgery: Vs 39(2): 239-243
Komatsubara, H.; Kitabayashi, M.; Kamimura, H.; Kawakami, B.; Kawamura, Y.; Takagi, M.; Imanaka, T. 1999: Modified thermostable DNA polymerase derived from pyrococcus sp KOD and DNA polymerase composition thereof for nucleic acid amplification. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)
Roberts, J.; Warters, R.; Wilmore, B. 1999: Modified thiolamines Improvements in radiation protection?. Amino Acids 17(1): 74
Akyurek, L.M.; Aoki, K.; Yang, Z.; San, H.; Richards, M.; Nabel, G.J.; Nabel, E.G. 1999: Modified thymidine kinase vector enhances prodrug cytotoxicity. Circulation 100(18): 1; 482
Miyazaki, K.; Higashi, S. 2003: Modified timp. Official Gazette of the United States Patent and Trademark Office Patents 1268(3)
Silverman, W.B. 2001: Modified tip of mechanical lithotripsy basket allows wire guide access. American Journal of Gastroenterology 96(10): 3041
Mccarron, K.F.; Mulinari Brenner, F.A.; Bergfeld, W.F. 2001: Modified transverse sections A proposed method for simplifying lab processing. Journal of Cutaneous Pathology 28(10): 577
Macleod, C. 2003: Modified trocar and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)
Austin, J.C.; Clement, M.R.; Canning, D.A. 2002: Modified tubularized transverse preputial island flap for repair of severe hypospadias. Journal of Urology 167(4 Suppl): 91
Raja, S.G. 2004: Modified ultrafiltration for paediatric cardiac surgical patients: additional benefits and concerns. Chinese Medical Journal 117(2): 318-319
Brueckner, S.; Siemens, H.J.; Leyh, R.G.; Stueber, W.; Katus, H.A.; Sievers, H.H. 1999: Modified ultrafiltration in adult cardiac surgery significantly reduces blood loss - No changes in coagulatory and fibrinolytic markers. Annals of Hematology 78(Suppl 1): A47
Luciani, G.B.; Menon, T.; Vecchi, B.; Mazzucco, A. 2000: Modified ultrafiltration reduces postoperative morbidity after adult open-heart operations A prospective, randomized clinical trial. Circulation 102(18): 2; 829
Harrop, R.; Connolly, N.; Mcneill, H.; Ryan, M.; Redchenko, I.; Kelleher, M.; Kingsman, S.M.; Hawkins, R.; Carroll, M.W. 2003: Modified vaccinia Ankara expressing the tumor associated antigen 5T4 induces immune responses in late stage colorectal cancer patients in a phase I/II clinical trial. Proceedings of the American Association for Cancer Research 44: 1275
Chaplin, P.; Howley, P.; Meisinger, C. 2004: Modified vaccinia ankara virus variant. Official Gazette of the United States Patent and Trademark Office Patents 1284(2)
Stahl Hennig, C.; Preugschat, A.; Stolte, N.; Ten Haaft, P.; Heeney, J.; Sutter, G.; Hunsmann, G. 2000: Modified vaccinia virus Ankara constructs expressing regulatory and structural SIV proteins as vaccine against SIV. Journal of Medical Primatology 29(3-4): 291
Hess, J.F.; Casselman, J.T.; FitzGerald, P. 2001: Modified version of pACT-2 that simplifies cloning with Ndei. Biotechniques 30(6): 1204; 1207
Nelsestuen, G.L. 2000: Modified vitamin K-dependent polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1230(4)
Levin, A.E. 2000: Modified western blot membrane and method for detecting lyme disease and other tick-borne diseases. Official Gazette of the United States Patent and Trademark Office Patents 1230(2)
Ziegler, E.E.; Carrie Fassler, A.L.; Haschke, F.; Nelson, S.E.; Jeter, J.M. 2000: Modified whey formula with protein-energy ratio 18g/100 kcal Metabolic balance studies in infants. JPGN 31(Suppl 2): S173
Mariss, P.; Herrmann, J.; Herbrik, S.; Emrich, D. 2001: Modified whole body scintigraphy and 131I-SPECT in differentiated thyroid carcinoma. Journal of Nuclear Medicine 42(5 Suppl): 323P
Kuntz, C.A.; Powers, B.E. 2000: Modified wide local excision for vaccine associated soft tissue sarcomas in cats. Veterinary Surgery 29(5): 481
Ferguson, E.G.W. 2010: Modified withdrawal periods and species indications. Veterinary Record 166(9): 281-282
Stayton, P.S. 2000: Modified-affinity streptavidin. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)
Wendorf, M.; Mir, N.A.; Beaudry, R.M. 1999: Modified-atmosphere packaging of fresh produce to prevent generation of anaerobic environments. HortScience 34(3): 510
Erturk, E.; Picha, D.H. 2001: Modified-atmosphere packaging of fresh-cut sweetpotatoes. HortScience 36(5): 850
Antonsson, P.; Bjork, P.; Dohlsten, M.; Hansson, J.; Forsberg, G.; Abrahmsen, L.; Kalland, T. 2003: Modified/chimeric superantigens and their use. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)
Mathiaparanam, P. 2002: Modifier compounds. Official Gazette of the United States Patent and Trademark Office Patents 1261(1)
Persu, A.; Stoenoiu, M.S.; Messiaen, T.; Horie, S.; Pirson, Y.; Chauveau, D.; Lens, X.M.; Jeunemaitre, X.; Devuyst, O. 2001: Modifier effect of the endothelial nitric oxide synthase gene in autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 544A
Jones, M.B.; Palmour, R.; Zwaigenbaum, L.; Szatmari, P. 2002: Modifier effects in autism at the DHB and MAO-A loci. American Journal of Human Genetics 71(4 Suppl): 470
Vardarli, I.; Janssen, B.; Baier, L.J.; Hanson, R.L.; Akkoyun, I.; Fischer, C.; Rohmeiss, P.; Basci, A.; Bartram, C.R.; Van Der Woude, F.J. 2001: Modifier gene for diabetic nephropathy in type 2 diabetes maps to 18q223-23. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 160A
Nadeau, J.H. 2003: Modifier genes and protective alleles in humans and mice. Current Opinion in Genetics and Development 13(3): 290-295
Dipple, K.M.; McCabe, E.R. 2000: Modifier genes convert "simple" Mendelian disorders to complex traits. Molecular Genetics and Metabolism 71(1-2): 43-50
Marian, A.J. 2002: Modifier genes for hypertrophic cardiomyopathy. Current Opinion in Cardiology 17(3): 242-252
Friedman, T.; Battey, J.; Kachar, B.; Riazuddin, S.; Noben-Trauth, K.; Griffith, A.; Wilcox, E. 2000: Modifier genes of hereditary hearing loss. Current Opinion in Neurobiology 10(4): 487-493
Schwab, M. 2001: Modifiers of breast cancer Does constitutional genomic instability in distal 9p signal the genomic site of a modifier locus?. International Journal of Molecular Medicine 8(Suppl 1): S64
Taylor, J.A.; Kwan Gett, T.S.eng C.; Mcmahon, E.M.J. 2003: Modifiying parental attitudes about antibiotics A randomized controlled Trial. Pediatric Research 53(4 Part 2): 216A-217A
Long, N. 1999: Modifying a clinical parenting therapy program for the managed-care environment. Journal of Investigative Medicine 47(2): 158A
Shon, Y.n Hee; Ha, Young Min; Jeong, Teuk Rae; Kim, Cheorl Ho; Nam, Kyung Soo 2001: Modifying action of chitosan oligosaccharide on 2-amino-3,8-dimethylimidazo quinoxaline -induced mutagenesis. Journal of Biochemistry and Molecular Biology 34(1): 90-94
Bourguignon, M. 2002: Modifying and supplying liquid nutritional feeding. Official Gazette of the United States Patent and Trademark Office Patents 1254(2)
Collins, M. 2001: Modifying antigen presenting cells. Cancer Gene Therapy 8(11): 910-911
Gu, W.; Pagel, P.S.; Warltier, D.C.; Kersten, J.R. 2003: Modifying cardiovascular risk in diabetes mellitus. Anesthesiology 98(3): 774-779
Jacobson, S.; Pillus, L. 1999: Modifying chromatin and concepts of cancer. Current Opinion in Genetics and Development 9(2): 175-184
Ranamukhaarachchi, D.G.; Rajeevan, M.S.; Vernon, S.D.; Unger, E.R. 2002: Modifying differential display polymerase chain reaction to detect relative changes in gene expression profiles. Analytical Biochemistry 306(2): 343-346
Sauer, S.L.; Anderson, R.C.; Swigart, R.; Fralish, J.; Carver, A. 2002: Modifying distance methods to estimate historical tree density from Government Land Office survey records. Transactions of the Illinois State Academy of Science 95(Suppl): 78
Sauer, S.L.; Anderson, R.C. 2003: Modifying distance methods to estimate historical tree density from general land survey records. Ecological Society of America Annual Meeting Abstracts 88: 296
Gjerde, D.T.; Taylor, P.D.; Haefele, R.M. 2001: Modifying double stranded DNA to enhance separations by matched ion polynucleotide chromatography. Official Gazette of the United States Patent and Trademark Office Patents 1245(1)
Bajinyan, S.A.; Malakyan, M.G.; Grigorayn, D.S.; Yeghiazarayn, D.E.; Ghazaryan, S.A. 2003: Modifying effect of Mn chelate on structure functional properties of erythrocyte membranes under the exposure of animal organism to ionizing radiation. Doklady Akademii Nauk 391(2): 263-265
Kosobryukhov, A.A.; Kreslavskii, V.D.; Khramov, R.N.; Bratkova, L.R.; Shchelokov, R.N. 2000: Modifying effect of low energetic luminescence light 625 nm on growth and photosynthesis of plants. Doklady Akademii Nauk 372(6): 827-829
Sharma, M.K.; Kumar, M.; Kumar, A. 2003: Modifying effect of spirulina fusiformis against mercury induced renal damages in Swiss Albino mice. Toxicology Letters (Shannon) 144(Suppl 1): s141
Baer, D.J.; Judd, J.T.; Tracy, R.P.; Iwane, M. 2000: Modifying effects of dietary fat and fatty acids on markers of inflammation. FASEB Journal 14(4): A482
Seike, N. 2001: Modifying effects of endocrine disrupting chemicals on multiorgan carcinogenesis in F344 rats. Proceedings of the American Association for Cancer Research 42: 882
Itoh, Y.; Katoh, S.; Yamazaki, Y.; Yokoyama, J.; Tajima, N. 2001: Modifying effects of vitamin A in combination with thiazolidinedione treatment. Diabetologia 44(Suppl 1): A202
Dharmaraj, S.; Silva, E.; Li, Y.Y.; Loyer, M.; Pina, A.L.; Sunness, J.; Koenekoop, R.K.; Maumenee, I.H. 2000: Modifying factors in Leber congenital amaurosis. IOVS Investigative Ophthalmology and Visual Science 41(4): S196
Valdemarsen, J.W.; Suuronen, P. 2003: Modifying fishing gear to achieve ecosystem objectives. Sinclair, M , Reprint Author, Valdimarsson, G Responsible fisheries in the marine ecosystem: 321-341
Gruber, M.; Ray, H.; Auser, P.; Blahut Beatty, L.; Bowley, S.; Mckersie, B.; Lloyd, A. 2001: Modifying flavonoid gene expression in alfalfa using maize regulatory genes. Plant Biology (Rockville) : 113
Jarvis, D.L. 2002: Modifying insect cell gylcosylation pathways with baculovirus expression vectors. Official Gazette of the United States Patent and Trademark Office Patents 1263(2)
Doyle, D.F.; Mangelsdorf, D.J.; Corey, D.R. 2000: Modifying ligand specificity of gene regulatory proteins. Current Opinion in Chemical Biology 4(1): 60-63
Chalmers, A.; Scott, S.; Marples, B.; Joiner, M. 2001: Modifying low-dose hyper-radiosensitivity by ribozyme mediated down-regulation of poly polymerase. British Journal of Cancer 85(Suppl 1): 36
Prokai-Tatrai, K.; Prokai, L. 2003: Modifying peptide properties by prodrug design for enhanced transport into the CNS. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 61: 155-188
Uludag, H.; Yang, J.; Gao, T.; Kousinioris, N.; Wohl, G.; Zernicke, R. 2001: Modifying proteins for an increased bone affinity. Journal of Bone and Mineral Research 16(Suppl 1): S450
Hopewell, J.W. 1999: Modifying radiation injury to normal tissues New opportunities. Meyer, J L Frontiers of Radiation Therapy and Oncology; Radiation injury: Advances in management and prevention 9-20
Galluccio, L.; Rovee Collier, C. 2002: Modifying reactivated memories of preverbal infants Repetition and age of memory effects. Developmental Psychobiology 41(1): 77
Yanagita, T. 2003: Modifying reagents and modified organic media for plant culture. Official Gazette of the United States Patent and Trademark Office Patents 1273(3)
Ailor, E.; Betenbaugh, M.J. 1999: Modifying secretion and post-translational processing in insect cells. Current Opinion in Biotechnology 10(2): 142-145
Toldi, J.; Farkas, T.; Kis, Z.; Perge, J.; Grimm, U.; Wolff, J.R. 2000: Modifying somatotopy in the primary motor cortex after facial nerve lesions in adult rats. Journal of Physiology (Cambridge) 526P: 71P
Vass, C.; Georgopoulos, M.; Vatanparast, Z. 2001: Modifying subscleral fluid pressure in an experimental model of mitomycin-C diffusion. IOVS Investigative Ophthalmology and Visual Science 42(4): S551
Reneker, L.W.; Shanavas, A.; Chen, Q.; Overbeek, P.A. 1999: Modifying the alpha-crystallin promoters to achieve transgene expression in both lens epithelial and fiber cells. IOVS Investigative Ophthalmology and Visual Science 40(4): S757
Wilson, G.D. 2001: Modifying the effect of radiation through biology. European Journal of Cancer 37(Suppl 6): S3
Nadeau, J.H. 2003: Modifying the message. Science 301(5635): 927-928
Lamont, William James Jr 2003: Modifying the microclimate for the production of vegetable crops. HortScience 38(5): 829
Staddon, J.M.; Morgan, M.L.; Ratcliffe, M.J. 2002: Modifying the permeability of physiological barriers. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)
Dowling, C. 2000: Modifying the production of ammonium and nitrate from urea bands with urease inhibitor Agrotain in a vertisol soil of the Darling Downs, Queensland. Communications in Soil Science and Plant Analysis 31(11-14): 1445, June/July
Brown, N.L.; Campos Reales, N.B.; Sukchawalit, R. 2003: Modifying the specificity of the HMA motif. Journal of Inorganic Biochemistry 96(1): 106, 15 July
Hwang, J.; Stupp, S.I. 2002: Modifying tissue surfaces by liquid crystal formation. Official Gazette of the United States Patent and Trademark Office Patents 1260(3)
Sutherland, S. 1999: Modifying wound care pain in patients with communication impairments. Journal of Burn Care and Rehabilitation 20(1 Part 2): S262
Declerck, A.C.; Dings, J.W. 2000: Modiodal is an effective alternative to methylphenidate in narcolepsy treatment. European Journal of Neurology 7(Suppl 3): 102-103
Berrang, P.G.; Bluger, H.V.; Klosowski, H.; Lupin, A.J. 2002: Modiolar hugging electrode array. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)
Kuzma, J.A. 2000: Modiolus-hugging cochlear electrodes. Official Gazette of the United States Patent and Trademark Office Patents 1234(5)
Merino-de-Miguel,S.; Huesca,M.; Gonzalez-Alonso,F. 2010: Modis reflectance and active fire data for burn mapping and assessment at regional level. Ecological Modelling 1(1): 67-74
Neyts, J.; Paeshuyse, J.; Leyssen, P.; Van Lommel, A.; De Clercq, E. 2001: Modoc virus encephalitis in SCID mice and hamsters, a model for the study of strategies for the treatment of Flavivirus encephalitis. Antiviral Research 50(1): A77
Leyssen, P.; Paeshuyse, J.; Van Lommel, A.; De Clercq, E.; Neyts, J. 2000: Modoc virus infections in SCID mice and hamsters as a model for Flavivirus encephalitis. Journal of Neurovirology 6(5): 453
Sherman, D.R.; Mollenauer, K.H. 2000: Modular CPR assist device. Official Gazette of the United States Patent and Trademark Office Patents 1234(4)
Sloots, A.; Uherek, C.; Beerli, R.R.; Wels, W. 2001: Modular DNA-carrier proteins for targeted gene delivery. Journal of Cancer Research and Clinical Oncology 127(Suppl 1): S51
Gothelf, K.V.; Thomsen, A.; Nielsen, M.; Cló, E.; Brown, R.S. 2004: Modular DNA-programmed assembly of linear and branched conjugated nanostructures. Journal of the American Chemical Society 126(4): 1044-1046
Smith, S. 2002: Modular NRPSs are monomeric. Chemistry and Biology 9(9): 955-956
Martinez, L.M.; Balceta, J.; Hahnen, K.; Addis, B.; Wood, T.J.; Turovskiy, R.; Murphy, R.O.; Maahs, T.D. 2004: Modular access port for device delivery. Official Gazette of the United States Patent and Trademark Office Patents 1280(3)
Tornier, A. 2002: Modular acetabular or cotyloid implant. Official Gazette of the United States Patent and Trademark Office Patents 1262(4)
Masini, M.A. 1999: Modular acetabular reconstruction plate. Official Gazette of the United States Patent and Trademark Office Patents 1229(3)
Sanders, A.P.; Revie, I.; Cornell, A.; Gross, A.E. 1999: Modular acetabular reinforcement system. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2366
Levine, Bruce Martin 2003: Modular adaptive optical subsystem for integration with a fundus camera body and CCD camera unit and improved fundus camera employing same. Official Gazette of the United States Patent and Trademark Office Patents 1271(4)
Schwenn, S.R.; Sandifer, A.T.; Davis, K.P. 2003: Modular adjustable prophylactic hip orthosis and adduction/abduction joint. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)
Flamme, D.D.; Orbach, A.; Haack, P.W.; Jacobson, E.D. 2000: Modular agricultural implement control system. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)
Pitesky, I. 2001: Modular allergy testing apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)
Graham, B.E.; Mccormick, S.A. 2004: Modular apparatus and method for shipping super frozen materials. Official Gazette of the United States Patent and Trademark Office Patents 1286(2)
Kaltenbach, P.; Van, D.G.or, T.A. 2004: Modular apparatus for chemical microanalysis. Official Gazette of the United States Patent and Trademark Office Patents 1284(1)
Newman, M.D.; Mccormick, S.A. 2002: Modular apparatus for cooling and freezing of a food product on a moving substrate. Official Gazette of the United States Patent and Trademark Office Patents 1261(3)
Newman, M.D.; Mccormick, S. 2001: Modular apparatus for cooling and freezing of food product on a moving substrate. Official Gazette of the United States Patent and Trademark Office Patents 1248(4)
Oscarson, S. 2003: Modular approach to the synthesis of motifs from all serotypes of the Cryptococcus neoformans GXM capsular polysaccharide. Abstracts of Papers American Chemical Society 226(1-2): CARB 22
Handy, S.T.; Zhang, Y.; Bregman, H.; Zhang, X.; Kudgus, R. 2002: Modular approach to the total synthesis of the lamellarins. Abstracts of Papers American Chemical Society 224(1-2): ORGN 814
Vanoni, M.A. 2000: Modular architecture of glutamate synthase A complex iron-sulfur flavoprotein. Biochemical Society Transactions 28(5): A123
Lob, G.; Fischer, H.J.; Steur, G.; Kranz, C. 2001: Modular artificial hip joint. Official Gazette of the United States Patent and Trademark Office Patents 1246(5)
Lopez, G.P.; Sklar, L.A.; Hampton, P.; Tender, L.; Opperman, K.; Rabinovich, E.; Jain, R.K.; Yan, J. 2003: Modular assembly for reagentless affinity separation and detection of analyte. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)
Robinson, R.R.; Liu, A.Y.; Horwitz, A.H.; Better, M.; Wall, R.; Lei, S.P.; Wilcox, G.L. 2001: Modular assembly of antibody genes, antibodies prepared thereby and use. Official Gazette of the United States Patent and Trademark Office Patents 1244(3)
Gage, F.H.; Suhr, S.T. 1999: Modular assembly retroviral vectors and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)
Townley, C.O. 2000: Modular ball and socket joint preferably with a ceramic head ball. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)
Knutson, P.L.; Augustine, S.D.; Rock, J.P. 2003: Modular bandage. Official Gazette of the United States Patent and Trademark Office Patents 1268(1)
Bergeron, P. 2001: Modular bifurcated vascular prosthesis. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)
Allen, J. 2003: Modular biofilter unit and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1268(3)
Moorman, J.W.; Bush, M.E.izabeth 2001: Modular biopsy and microwave ablation needle delivery apparatus adapted to in situ assembly and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1251(4)
Eppinger, H.; Visak, J. 2002: Modular bite block and sensor holder apparatus for dental x-ray procedures. Official Gazette of the United States Patent and Trademark Office Patents 1255(1)
Lindsay, E.J. 1999: Modular blood treatment cartridge. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2409-2410
Grooms, J.M.; Carter, K.; Schneider, R.T. 1999: Modular bone grinder and snap-in grinder head. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)
Sehlin, S.R.; Phillis, T.C. 2004: Modular ceramic oxygen system. Official Gazette of the United States Patent and Trademark Office Patents 1285(5)
Bylo, John Michael 2004: Modular combat load system. Official Gazette of the United States Patent and Trademark Office Patents 1282(1)
Casanova, M.F. 2003: Modular concepts of brain organization and the neuropathology of psychiatric conditions. Psychiatry Research 118(1): 101-102